Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Breast Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 682 articles:
HTML format



Single Articles


    August 2022
  1. DRAPALIK LM, Amin AL, Miller ME
    ASO Author Reflections: Inflammatory Breast Cancer: The Exception to De-escalation of Care for Older Women?
    Ann Surg Oncol. 2022 Aug 5. pii: 10.1245/s10434-022-12338.
    PubMed    


  2. LI C, Lu N, He Z, Tan Y, et al
    ASO Visual Abstract: A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12078.
    PubMed    


  3. FISHER CS
    Neoadjuvant Chemotherapy for Breast Cancer: The Ultimate "Spy".
    Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12153.
    PubMed    


  4. DRAPALIK LM, Hue JJ, Simpson A, Freyvogel M, et al
    ASO Visual Abstract: Guideline-Consistent Treatment for Inflammatory Breast Cancer Provides Associated Survival Benefit Independent of Age.
    Ann Surg Oncol. 2022 Aug 4. pii: 10.1245/s10434-022-12318.
    PubMed    


  5. TOLLAN CJ, Pantiora E, Valachis A, Karakatsanis A, et al
    ASO Visual Abstract: A Systematic Review and Meta-analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.
    Ann Surg Oncol. 2022 Aug 3. pii: 10.1245/s10434-022-12325.
    PubMed    


  6. GENTLE CK, Alkhatib H, Valente SA, Tu C, et al
    ASO Visual Abstract: Stage IV Non-Breast Cancer Patients and Screening Mammography: It is Time to Stop.
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12214.
    PubMed    


  7. PORTERHOUSE MD, Paul S, Lieberenz JL, Stempel LR, et al
    ASO Visual Abstract: Black Women Are Less Likely to Be Classified as High Risk for Breast Cancer Using Tyrer-Cuzick 8 Model.
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12243.
    PubMed    


  8. PILEWSKIE M, Sevilimedu V, Eroglu I, Le T, et al
    ASO Visual Abstract: How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR(+)/HER2(-) Breast Cancer in the Post-RxPONDER Era?
    Ann Surg Oncol. 2022 Aug 2. pii: 10.1245/s10434-022-12246.
    PubMed    


  9. SHUBECK S, Sevilimedu V, Berger E, Robson M, et al
    Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy.
    Ann Surg Oncol. 2022;29:4706-4713.
    PubMed     Abstract available


  10. NELSON JA, Allen RJ Jr
    ASO Author Reflections: Deeper Understanding of Patient-Reported Outcomes in Breast Reconstruction Patients Not Requiring Radiation Therapy: Harnessing Propensity Matching Methodology.
    Ann Surg Oncol. 2022;29:5276-5277.
    PubMed    


  11. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
    ASO Author Reflections: Axillary Management in Mastectomy Patients with Limited Nodal Burden.
    Ann Surg Oncol. 2022;29:4750-4751.
    PubMed    


  12. ARDON AE, George JE 3rd, Gupta K, O'Rourke MJ, et al
    The Use of Pectoralis Blocks in Breast Surgery: A Practice Advisory and Narrative Review from the Society for Ambulatory Anesthesia (SAMBA).
    Ann Surg Oncol. 2022;29:4777-4786.
    PubMed     Abstract available


  13. DINOME ML, Marzese DM
    ASO Author Reflections: Entering the Era of Biomarker-Driven Management of the Axilla.
    Ann Surg Oncol. 2022;29:4725-4726.
    PubMed    


  14. NELSON JA, Chu JJ, McCarthy CM, Stern CS, et al
    BREAST-Q REACT: Clinical Reference Values for the BREAST-Q in Post-mastectomy Breast Reconstruction Patients.
    Ann Surg Oncol. 2022;29:5280-5293.
    PubMed     Abstract available


  15. ARDON AE, George JE 3rd, Gupta K, O'Rourke MJ, et al
    ASO Author Reflections: SAMBA's Practice Advisory for the Use of Pectoralis Blocks in Breast Surgery: Overview and Lingering Questions.
    Ann Surg Oncol. 2022;29:4787-4788.
    PubMed    


  16. NELSON JA, Shamsunder MG, Myers PL, Polanco TO, et al
    Matched Preliminary Analysis of Patient-Reported Outcomes following Autologous and Implant-Based Breast Reconstruction.
    Ann Surg Oncol. 2022;29:5266-5275.
    PubMed     Abstract available


  17. NELSON JA, Shamsunder MG, Myers PL, Polanco TO, et al
    A Matched Preliminary Analysis of Patient-Reported Outcomes After Autologous and Implant-Based Breast Reconstruction.
    Ann Surg Oncol. 2022;29:5278-5279.
    PubMed    


  18. CHU JJ, Nelson JA
    ASO Author Reflections: Patient-Reported Outcomes for Breast Reconstruction Clinical Practice.
    Ann Surg Oncol. 2022;29:5294-5295.
    PubMed    


  19. HUYNH V, Vemuru S, Hampanda K, Pettigrew J, et al
    No One-Size-Fits-All: Sexual Health Education Preferences in Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12126.
    PubMed     Abstract available


  20. CO LMB, Dee EC, Eala MAB, Ang SD, et al
    Access to Surgical Treatment for Breast Cancer in the Philippines.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12311.
    PubMed     Abstract available


  21. UHLMANN RA, Mott SL, Curry M, Phadke S, et al
    Analysis of the Understanding and Worry about Lymphedema of Patients with Breast Cancer.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-12189.
    PubMed     Abstract available


  22. BAYARD S, Bea VJ
    Disparities in Time to Treatment for Breast Cancer: Shifting Focus to the Root Cause.
    Ann Surg Oncol. 2022 Aug 1. pii: 10.1245/s10434-022-11948.
    PubMed    


    July 2022
  23. KLIMBERG VS
    Keynote Address at the ASBrS 2022 Annual Meeting Low-Risk Breast Cancer: When Is Local Therapy Enough?
    Ann Surg Oncol. 2022 Jul 30. pii: 10.1245/s10434-022-12125.
    PubMed     Abstract available


  24. NAKHLIS F
    ASO Visual Abstract: Inflammatory Breast Cancer-Is There a Role for De-escalation of Surgery?
    Ann Surg Oncol. 2022 Jul 30. pii: 10.1245/s10434-022-12217.
    PubMed    


  25. CHEN JC, Li Y, Fisher JL, Bhattacharyya O, et al
    ASO Visual Abstract: Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12183.
    PubMed    


  26. PEIFER HG, Raker C, Pesek S, Edmonson D, et al
    ASO Visual Abstract: Breast-Specific Sensuality in Breast Cancer Survivors - Sexually Active or Not.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12249.
    PubMed    


  27. TASOULIS MK, Karakatsanis A
    ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment.
    Ann Surg Oncol. 2022 Jul 29. pii: 10.1245/s10434-022-12310.
    PubMed    


  28. KANTOR O, Burstein HJ, King TA, Shak S, et al
    ASO Visual Abstract: Expanding Staging Criteria in T1-2N0 Hormone Receptor-Positive Breast Cancer Patients Enrolled in TAILORx.
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12294.
    PubMed    


  29. WILLIAMS AD, Dang CT, Sevilimedu V, Morrow M, et al
    ASO Visual Abstract: Neoadjuvant Chemotherapy for Breast Cancer in the Elderly-Are We Accomplishing Our Treatment Goals?
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12282.
    PubMed    


  30. BAYARD S, Bea VJ
    ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action.
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-11981.
    PubMed    


  31. MONTAGNA G, Lee MK, Sevilimedu V, Barrio AV, et al
    Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2022 Jul 28. pii: 10.1245/s10434-022-12240.
    PubMed     Abstract available


  32. KANTOR O, Burstein HJ, King TA, Shak S, et al
    Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx.
    Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12225.
    PubMed     Abstract available


  33. OROZCO JIJ, Keller JK, Chang SC, Fancher CE, et al
    ASO Visual Abstract: Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer Undergoing Upfront Surgery.
    Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12279.
    PubMed    


  34. OROZCO JIJ, Keller JK, Chang SC, Fancher CE, et al
    Impact of Locoregional Treatment on Survival in Young Patients with Early-Stage Breast Cancer undergoing Upfront Surgery.
    Ann Surg Oncol. 2022 Jul 27. pii: 10.1245/s10434-022-12190.
    PubMed     Abstract available


  35. CHICHURA A, Attai DJ, Kuchta K, Nicholson K, et al
    Male Breast Cancer Patient and Surgeon Experience: The Male WhySurg Study.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12135.
    PubMed     Abstract available


  36. KENNARD K, Wang O, Kjelstrom S, Larson S, et al
    ASO Visual Abstract: Outcomes of Abbreviated MRI (Ab-MRI) for Women of Any Breast Cancer Risk and Breast Density in a Community Academic Setting.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12247.
    PubMed    


  37. BOUGHEY JC, Hoskin TL, Day CN, Goetz MP, et al
    Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12191.
    PubMed     Abstract available


  38. SANDERS SB, Hoskin TL, Stafford AP, Boughey JC, et al
    ASO Visual Abstract: Factors Influencing Non-Sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12270.
    PubMed    


  39. SORAN A, Ozbas S, Ozcinar B, Isik A, et al
    Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02.
    Ann Surg Oncol. 2022 Jul 25. pii: 10.1245/s10434-022-12239.
    PubMed     Abstract available


  40. WILLIAMS AD, Dang CT, Sevilimedu V, Morrow M, et al
    Neoadjuvant Chemotherapy for Breast Cancer In the Elderly: Are We Accomplishing Our Treatment Goals?
    Ann Surg Oncol. 2022 Jul 24. pii: 10.1245/s10434-022-12206.
    PubMed     Abstract available


  41. BOUGHEY JC, Hoskin TL, Day CN, Goetz MP, et al
    ASO Visual Abstract: Nodal Pathologic Complete Response Rates in Luminal Breast Cancer Vary by Genomic Risk.
    Ann Surg Oncol. 2022 Jul 24. pii: 10.1245/s10434-022-12278.
    PubMed    


  42. NAKHLIS F, Katlin FD, Grossmith SC, DiPasquale A, et al
    ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
    Ann Surg Oncol. 2022 Jul 21. pii: 10.1245/s10434-022-12272.
    PubMed    


  43. KENNARD K, Wang O, Kjelstrom S, Larson S, et al
    Outcomes of Abbreviated MRI (Ab-MRI) for Women of any Breast Cancer Risk and Breast Density in a Community Academic Setting.
    Ann Surg Oncol. 2022 Jul 20. pii: 10.1245/s10434-022-12194.
    PubMed     Abstract available


  44. FARLEY CR, Irwin S, Adesoye T, Sun SX, et al
    Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment.
    Ann Surg Oncol. 2022 Jul 19. pii: 10.1245/s10434-022-12142.
    PubMed     Abstract available


  45. TOLLAN CJ, Pantiora E, Valachis A, Karakatsanis A, et al
    A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12197.
    PubMed     Abstract available


  46. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
    Chyle Leak After Axillary Node Clearance in Breast Cancer Surgery-A Rare Complication and a Proposed Management Strategy from the British and Italian Experience.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12094.
    PubMed     Abstract available


  47. PILEWSKIE M, Sevilimedu V, Eroglu I, Le T, et al
    How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR(+)/HER2(-) Breast Cancer in the Post-RxPONDER Era?
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12193.
    PubMed     Abstract available


  48. GENTLE CK, Alkhatib H, Valente SA, Tu C, et al
    Stage IV Non-breast Cancer Patients and Screening Mammography: It is Time to Stop.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12132.
    PubMed     Abstract available


  49. OROZCO JIJ, Le J, Ensenyat-Mendez M, Baker JL, et al
    ASO Visual Abstract: Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Jul 18. pii: 10.1245/s10434-022-12245.
    PubMed    


  50. COBB AN, Sun SX
    ASO Author Reflections: Inflammatory Breast Cancer with Supraclavicular Nodal Involvement-Favorable Long-Term Outcomes can be Achieved.
    Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12235.
    PubMed    


  51. OROZCO JIJ, Le J, Ensenyat-Mendez M, Baker JL, et al
    Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12143.
    PubMed     Abstract available


  52. AMLICKE MJ, Park J, Agala CB, Casey DL, et al
    ASO Visual Abstract: Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2022 Jul 16. pii: 10.1245/s10434-022-12163.
    PubMed    


  53. NAKHLIS F
    Inflammatory Breast Cancer: Is There a Role for Deescalation of Surgery?
    Ann Surg Oncol. 2022 Jul 15. pii: 10.1245/s10434-022-12138.
    PubMed     Abstract available


  54. SU GH, Jiang L, Xiao Y, Zheng RC, et al
    ASO Visual Abstract: A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2022 Jul 15. pii: 10.1245/s10434-022-12010.
    PubMed    


  55. COBB AN, Diao K, Teshome M, Lucci A, et al
    Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement.
    Ann Surg Oncol. 2022 Jul 14. pii: 10.1245/s10434-022-12144.
    PubMed     Abstract available


  56. SANDERS SB, Hoskin TL, Stafford AP, Boughey JC, et al
    Factors Influencing Non-sentinel Lymph Node Involvement in Patients with Positive Sentinel Lymph Node(s) After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12064.
    PubMed     Abstract available


  57. AMLICKE MJ, Spanheimer PM
    ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12175.
    PubMed    


  58. LAWS A, Pastorello R, Dey T, Grossmith S, et al
    ASO Visual Abstract: Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
    Ann Surg Oncol. 2022 Jul 13. pii: 10.1245/s10434-022-12165.
    PubMed    


  59. FLANAGAN MR, Sharifi N, Gadi VK
    ASO Author Reflections: Inheritance of Adrenal Permissive HSD3B1 Genotype Negatively Impacts Outcomes in Hormone Receptor-Positive Postmenopausal Breast Cancer.
    Ann Surg Oncol. 2022 Jul 11. pii: 10.1245/s10434-022-12091.
    PubMed    


  60. GUTNIK LA, Fish LJ, Gallagher J, Greenup RA, et al
    'At All Costs': Breast Cancer Patient Responses to Cost Transparency and Communication.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12160.
    PubMed    


  61. KANTOR O, Weiss A, Burstein HJ, Mittendorf EA, et al
    ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12081.
    PubMed    


  62. ASHOOR A, Lissidini G, Datta U, Bertoldi L, et al
    ASO Author Reflections: Chyle Leak after Axillary Node Clearance in Breast Cancer Surgery, a Successful Management Approach from Leading Centres.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12122.
    PubMed    


  63. LAWS A, Pastorello R, Dey T, Grossmith S, et al
    Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I-III Breast Cancer.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12054.
    PubMed     Abstract available


  64. ABEL MK, Shui AM, Chien AJ, Rugo HS, et al
    The 21-Gene Recurrence Score in Clinically High-Risk Lobular and Ductal Breast Cancer: A National Cancer Database Study.
    Ann Surg Oncol. 2022 Jul 9. pii: 10.1245/s10434-022-12065.
    PubMed     Abstract available


  65. WONG SM, Ferroum A, Apostolova C, Alhassan B, et al
    ASO Visual Abstract: Incidence of Occult Breast Cancer in Carriers of BRCA1/2 and Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy-When is Sentinel Lymph Node Biopsy Indicated?
    Ann Surg Oncol. 2022 Jul 8. pii: 10.1245/s10434-022-12011.
    PubMed    


  66. ABEL MK, Shui AM, Chien AJ, Rugo HS, et al
    ASO Visual Abstract: The 21-Gene Recurrence Score in Clinically High Risk Lobular and Ductal Breast Cancer-A National Cancer Database Study.
    Ann Surg Oncol. 2022 Jul 7. pii: 10.1245/s10434-022-12120.
    PubMed    


  67. HIEKEN TJ, Hoskin TL
    ASO Author Reflections: Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
    Ann Surg Oncol. 2022 Jul 7. pii: 10.1245/s10434-022-12181.
    PubMed    


  68. COOPEY SB
    Supraclavicular and Contralateral Axillary Lymph Node Involvement in Breast Cancer Patients.
    Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12134.
    PubMed     Abstract available


  69. PILTIN MA, Boughey JC
    ASO Author Reflections: In an Era of De-escalation, Are We Still Doing Too Much for Stage 0 Breast Cancer?
    Ann Surg Oncol. 2022 Jul 6. pii: 10.1245/s10434-022-12169.
    PubMed    


  70. PORTERHOUSE MD, Paul S, Lieberenz JL, Stempel LR, et al
    Black Women Are Less Likely to Be Classified as High-Risk for Breast Cancer Using the Tyrer-Cuzick 8 Model.
    Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12140.
    PubMed     Abstract available


  71. MARTINEZ EO, Jorns JM, Kong AL, Cortina CS, et al
    ASO Author Reflections: Rare Breast Cancer Subtypes and the Role for Precision Oncology.
    Ann Surg Oncol. 2022 Jul 5. pii: 10.1245/s10434-022-12137.
    PubMed    


  72. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
    ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays.
    Ann Surg Oncol. 2022 Jul 4. pii: 10.1245/s10434-022-12069.
    PubMed    


  73. BOUGHEY JC, Hoskin TL, Goetz MP
    ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer-Effects of Age and Tumor Ki67.
    Ann Surg Oncol. 2022 Jul 1. pii: 10.1245/s10434-022-12004.
    PubMed    


  74. FLANAGAN MR, Doody DR, Voutsinas J, Wu Q, et al
    Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2022 Jul 1. pii: 10.1245/s10434-022-12088.
    PubMed     Abstract available


    June 2022
  75. NAKHLIS F, Katlin FD, Grossmith SC, DiPasquale A, et al
    Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS.
    Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12066.
    PubMed     Abstract available


  76. HIEKEN TJ, Boughey JC, Degnim AC, Glazebrook KN, et al
    Inflammatory Breast Cancer: Durable Breast Cancer-Specific Survival for HER2-Positive Patients with a Pathologic Complete Response to Neoadjuvant Therapy.
    Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12037.
    PubMed    


  77. LI C, Lu N, He Z, Tan Y, et al
    A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2022 Jun 30. pii: 10.1245/s10434-022-12034.
    PubMed     Abstract available


  78. KANTOR O, Weiss A, Burstein HJ, Mittendorf EA, et al
    Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.
    Ann Surg Oncol. 2022 Jun 28. pii: 10.1245/s10434-022-12032.
    PubMed     Abstract available


  79. AMLICKE MJ, Park J, Agala CB, Casey DL, et al
    Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2022 Jun 25. pii: 10.1245/s10434-022-12056.
    PubMed     Abstract available


  80. SCHERMERHORN MC, Grunvald MW, O'Donoghue CM, Rao RD, et al
    Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer.
    Ann Surg Oncol. 2022 Jun 24. pii: 10.1245/s10434-022-12001.
    PubMed     Abstract available


  81. KUS T, Aktas G
    Correction to : Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
    Ann Surg Oncol. 2022 Jun 22. pii: 10.1245/s10434-022-12072.
    PubMed    


  82. MCGUIRE KP, Arthur DW, Mamounas EP
    Updates on Management of Hereditary Breast Cancer: New Data on PARP Inhibitors Change Recommendations Regarding the Multidisciplinary Care of Breast Cancer Patients with BRCA Mutations.
    Ann Surg Oncol. 2022 Jun 18. pii: 10.1245/s10434-022-12048.
    PubMed    


  83. HUANG X, Luo Z, Fu DY
    ASO Author Reflections: Simplified Nomogram Predictive of Survival for Young Breast Cancer Patients.
    Ann Surg Oncol. 2022 Jun 17. pii: 10.1245/s10434-022-11966.
    PubMed    


  84. SU GH, Jiang L, Xiao Y, Zheng RC, et al
    A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2022 Jun 16. pii: 10.1245/s10434-022-11958.
    PubMed     Abstract available


  85. CHEN JC, Bazan JG, Obeng-Gyasi S
    ASO Author Reflections: Surgical Management Should be Considered in Patients with De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Jun 14. pii: 10.1245/s10434-022-12016.
    PubMed    


  86. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
    ASO Visual Abstract: Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting 1-2 Metastatic Sentinel Lymph Nodes: The Multicenter Randomized Clinical Trial SINODAR-ONE.
    Ann Surg Oncol. 2022 Jun 12. pii: 10.1245/s10434-022-11908.
    PubMed    


  87. CHEN JC, Li Y, Fisher JL, Bhattacharyya O, et al
    Modified Radical Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2022 Jun 8. pii: 10.1245/s10434-022-11975.
    PubMed     Abstract available


  88. KHAN SA, Schuetz S, Hosseini O
    Correction to: Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
    Ann Surg Oncol. 2022 Jun 8. pii: 10.1245/s10434-022-11995.
    PubMed    


  89. CROWN A, Muhsen S, Sevilimedu V, Kelvin J, et al
    Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
    Ann Surg Oncol. 2022 Jun 7. pii: 10.1245/s10434-022-11910.
    PubMed     Abstract available


  90. EISENBERG ER, Weiss A, Prakash I, Skamene S, et al
    Surgical Management and Contralateral Breast Cancer Risk in Women with History of Radiation Therapy for Hodgkin Lymphoma: Results from a Population-Based Cohort.
    Ann Surg Oncol. 2022 Jun 6. pii: 10.1245/s10434-022-11947.
    PubMed     Abstract available


  91. HUANG X, Luo Z, Liang W, Xie G, et al
    ASO Visual Abstract: Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2022 Jun 5. pii: 10.1245/s10434-022-11968.
    PubMed    


  92. KUS T, Aktas G
    Should We Completely Exclude Locoregional Therapy for the Primary Tumor from Our Clinical Practice in De Novo Metastatic Breast Cancer?
    Ann Surg Oncol. 2022 Jun 4. pii: 10.1245/s10434-022-11979.
    PubMed     Abstract available


  93. HUANG X, Luo Z, Liang W, Xie G, et al
    Survival Nomogram for Young Breast Cancer Patients Based on the SEER Database and an External Validation Cohort.
    Ann Surg Oncol. 2022 Jun 3. pii: 10.1245/s10434-022-11911.
    PubMed     Abstract available


  94. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
    ASO Visual Abstract: Additional Work-Ups Recommended During Preoperative Breast MRI, Methods to Gain Efficiency and Limit Confusion.
    Ann Surg Oncol. 2022;29:3851-3852.
    PubMed    


  95. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
    ASO Visual Abstract: Mastectomy or Margin Reexcision? A Nomogram for Close/Positive Margins after Lumpectomy for DCIS.
    Ann Surg Oncol. 2022;29:3749.
    PubMed    


  96. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    ASO Visual Abstract: Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
    Ann Surg Oncol. 2022;29:3838.
    PubMed    


  97. WEISS A, King C, Grossmith S, Portnow L, et al
    ASO Visual Abstract: How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective Consecutive Patient Cohort Study.
    Ann Surg Oncol. 2022;29:3774-3775.
    PubMed    


  98. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional Study.
    Ann Surg Oncol. 2022;29:3829-3835.
    PubMed     Abstract available


  99. MITSUEDA R, Gen A, Fujiki Y, Gondo N, et al
    ASO Author Reflections: Patients' Satisfaction After Breast Conserving Surgery Using the Suture Scaffold Technique.
    Ann Surg Oncol. 2022;29:3836-3837.
    PubMed    


  100. MAIMONE S, Morozov AP, Li Z, Craver EC, et al
    Additional Workups Recommended During Preoperative Breast MRI: Methods to Gain Efficiency and Limit Confusion.
    Ann Surg Oncol. 2022;29:3839-3848.
    PubMed     Abstract available


  101. MAIMONE S, McLaughlin SA
    ASO Author Reflections: Optimizing Additional Workups from Preoperative Breast MRI.
    Ann Surg Oncol. 2022;29:3849-3850.
    PubMed    


  102. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
    ASO Visual Abstract: Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:3799.
    PubMed    


  103. LIANG DH, Black D, Yi M, Luo CK, et al
    Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.
    Ann Surg Oncol. 2022;29:3822-3828.
    PubMed     Abstract available


  104. HUANG CC, Tsai YF, Liu CY, Lien PJ, et al
    Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.
    Ann Surg Oncol. 2022;29:3578-3590.
    PubMed     Abstract available


  105. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
    ASO Visual Abstract: Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
    Ann Surg Oncol. 2022;29:3739.
    PubMed    


  106. REDFERN RE, Shermis RB
    ASO Visual Abstract: Initial Experience Using Magseed for Breast Lesion Localization Compared to Wire-Guided Localization-Analysis of Volume and Margin Clearance Rates.
    Ann Surg Oncol. 2022;29:3784.
    PubMed    


  107. MORARASU S, Clancy C, Ghetu N, Musina AM, et al
    Impact of Quilting Sutures on Surgical Outcomes After Mastectomy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2022;29:3785-3797.
    PubMed     Abstract available


  108. REDFERN RE, Shermis RB
    Initial Experience Using Magseed for Breast Lesion Localization Compared With Wire-Guided Localization: Analysis of Volume and Margin Clearance Rates.
    Ann Surg Oncol. 2022;29:3776-3783.
    PubMed     Abstract available


  109. SILVERSTEIN MJ, Epstein MS, Chen P, Lin K, et al
    Recurrence and Survival Rates for 1400 Early Breast Tumors Treated with Intraoperative Radiation Therapy (IORT).
    Ann Surg Oncol. 2022;29:3726-3736.
    PubMed     Abstract available


  110. MARTINS MAIA C, Siderides C, Jaffer S, Weltz C, et al
    Mastectomy or Margin Re-excision? A Nomogram for Close/Positive Margins After Lumpectomy for DCIS.
    Ann Surg Oncol. 2022;29:3740-3748.
    PubMed     Abstract available


  111. WEISS A, King C, Grossmith S, Portnow L, et al
    How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study.
    Ann Surg Oncol. 2022;29:3764-3771.
    PubMed     Abstract available


  112. KOPKASH K, Novak K, Murphy R, Deliere A, et al
    ASO Visual Abstract: Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and an Operating Room Positioning Protocol.
    Ann Surg Oncol. 2022;29:3863.
    PubMed    


  113. CORTINA CS, Kong AL
    ASO Author Reflections: The Evolving Multidisciplinary Management of the Axilla in Mastectomy Patients.
    Ann Surg Oncol. 2022;29:3853-3854.
    PubMed    


  114. JU T, Momeni A, Wapnir I
    ASO Author Reflections: Preventing Nipple Loss by Surgical Delay in Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2022;29:3855-3856.
    PubMed    


    May 2022
  115. SU GH, Jiang L, Xiao Y, Zheng RC, et al
    ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.
    Ann Surg Oncol. 2022 May 29. pii: 10.1245/s10434-022-11960.
    PubMed    


  116. WONG SM, Ferroum A, Apostolova C, Alhassan B, et al
    Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
    Ann Surg Oncol. 2022 May 26. pii: 10.1245/s10434-022-11916.
    PubMed     Abstract available


  117. KHAN SA, Schuetz S, Husseini O
    Primary-Site Local Therapy for Patients with De Novo Metastatic Breast Cancer: An Educational Review.
    Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11900.
    PubMed     Abstract available


  118. ZIPKIN RJ, Schaefer A, Wang C, Loehrer AP, et al
    Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.
    Ann Surg Oncol. 2022 May 24. pii: 10.1245/s10434-022-11834.
    PubMed     Abstract available


  119. RELATION T, Bhattacharyya O, Oppong BA
    ASO Author Reflections: Surgery Refusal in Breast Cancer Has a Disproportionate Impact on Black and Hispanic Women.
    Ann Surg Oncol. 2022 May 17. pii: 10.1245/s10434-022-11906.
    PubMed    


  120. BOUGHEY JC, Blair SL, Subhedar PD, Edge SB, et al
    The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer.
    Ann Surg Oncol. 2022 May 16. pii: 10.1245/s10434-022-11899.
    PubMed    


  121. BOUGHEY JC, Hoskin TL, Goetz MP
    Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer: Effects of Age and Tumor Ki67.
    Ann Surg Oncol. 2022 May 15. pii: 10.1245/s10434-022-11871.
    PubMed     Abstract available


  122. TINTERRI C, Gentile D, Gatzemeier W, Sagona A, et al
    Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1-2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial.
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11866.
    PubMed     Abstract available


  123. HUGHES KS, Yin K
    A Woman Needs to Know She Is a BRCA Carrier Before She Develops Breast Cancer.
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11860.
    PubMed    


  124. ZIPKIN RJ, Schaefer A, Wang C, Loehrer AP, et al
    ASO Visual Abstract: Rural-Urban Differences in Breast Cancer Surgical Delays in Medicare Beneficiaries.
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11877.
    PubMed    


  125. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
    ASO Visual Abstract: Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: An Alternative to Sentinel-Node-Biopsy?
    Ann Surg Oncol. 2022 May 12. pii: 10.1245/s10434-022-11876.
    PubMed    


  126. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
    ASO Visual Abstract: Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
    Ann Surg Oncol. 2022 May 9. pii: 10.1245/s10434-022-11743.
    PubMed    


  127. RELATION T, Ndumele A, Bhattacharyya O, Fisher JL, et al
    Surgery Refusal Among Black and Hispanic Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 May 5. pii: 10.1245/s10434-022-11832.
    PubMed     Abstract available


  128. MATAR R, Sevilimedu V, Gemignani ML, Morrow M, et al
    ASO Visual Abstract: Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women With Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy.
    Ann Surg Oncol. 2022 May 2. pii: 10.1245/s10434-022-11795.
    PubMed    


  129. VERBUS EA, Khan TM, Hernandez JM, Kulkarni S, et al
    Evaluating the Effects of a Tissue Selective Estrogen Complex (TSEC) in Women with Newly Diagnosed Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2022;29:2769-2770.
    PubMed    


    April 2022
  130. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
    Preoperative Sonographic Prediction of Limited Axillary Disease in Patients with Primary Breast Cancer Meeting the Z0011 Criteria: an Alternative to Sentinel Node Biopsy?
    Ann Surg Oncol. 2022 Apr 29. pii: 10.1245/s10434-022-11829.
    PubMed     Abstract available


  131. RADOSA JC, Solomayer EF, Deeken M, Minko P, et al
    ASO Author Reflections: An Alternative to Sentinel-Node Biopsy? Preoperative Sonographic Prediction of Limited Axillary Disease in Breast Cancer Patients Meeting the Z0011 Criteria.
    Ann Surg Oncol. 2022 Apr 29. pii: 10.1245/s10434-022-11845.
    PubMed    


  132. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
    ASO Visual Abstract: Contemporary Axillary Management in cT1-2N0 Breast Cancer with 1-2 Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Ann Surg Oncol. 2022 Apr 28. pii: 10.1245/s10434-022-11818.
    PubMed    


  133. BURKBAUER L, Goldbach M, Hoffman DI, Giannakou A, et al
    ASO Visual Abstract: Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
    Ann Surg Oncol. 2022 Apr 28. pii: 10.1245/s10434-022-11608.
    PubMed    


  134. KARZAI S, Port E, Siderides C, Valente C, et al
    ASO Visual Abstract: Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2022 Apr 27. pii: 10.1245/s10434-022-11636.
    PubMed    


  135. COLLIN LJ, Ross-Driscoll K, Nash R, Miller-Kleinhenz JM, et al
    ASO Visual Abstract: Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality: Delay, Facilities, and Breast Cancer Mortality.
    Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11794.
    PubMed    


  136. SONG JH, Kantor O, Mittendorf EA, King TA, et al
    ASO Visual Abstract: Race and Site of Care Impact Treatment Delays for Older Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11593.
    PubMed    


  137. ADESOYE T, Sun SX, Schaverien MV, Woodward WA, et al
    Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?
    Ann Surg Oncol. 2022 Apr 26. pii: 10.1245/s10434-022-11788.
    PubMed    


  138. MATAR R, Sevilimedu V, Gemignani ML, Morrow M, et al
    Impact of Endocrine Therapy Adherence on Outcomes in Elderly Women with Early-Stage Breast Cancer Undergoing Lumpectomy Without Radiotherapy.
    Ann Surg Oncol. 2022 Apr 24. pii: 10.1245/s10434-022-11728.
    PubMed     Abstract available


  139. STAFFORD AP, Hoskin TL, Day CN, Sanders SB, et al
    Contemporary Axillary Management in cT1-2N0 Breast Cancer with One or Two Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database.
    Ann Surg Oncol. 2022 Apr 22. pii: 10.1245/s10434-022-11759.
    PubMed     Abstract available


  140. MATAR R, Morrow M
    ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence.
    Ann Surg Oncol. 2022 Apr 22. pii: 10.1245/s10434-022-11769.
    PubMed    


  141. WHITWORTH P, Beitsch PD, Pellicane JV, Baron PL, et al
    ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 19. pii: 10.1245/s10434-022-11711.
    PubMed    


  142. COLLIN LJ, Ross-Driscoll K, Nash R, Miller-Kleinhenz JM, et al
    Time to Surgical Treatment and Facility Characteristics as Potential Drivers of Racial Disparities in Breast Cancer Mortality.
    Ann Surg Oncol. 2022 Apr 18. pii: 10.1245/s10434-022-11720.
    PubMed     Abstract available


  143. SCHWARTZ T
    Personal Systemic Therapy Decision-Making has Officially Arrived for Node-Positive Breast Cancer.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11689.
    PubMed    


  144. ENSENYAT-MENDEZ M, Runger D, Orozco JIJ, Le J, et al
    ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11744.
    PubMed    


  145. MINAMI CA, Jin G, Schonberg MA, Freedman RA, et al
    ASO Visual Abstract: Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 16. pii: 10.1245/s10434-022-11778.
    PubMed    


  146. ENSENYAT-MENDEZ M, Runger D, Orozco JIJ, Le J, et al
    Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen Receptor-Positive, Clinically Node-Positive Disease.
    Ann Surg Oncol. 2022 Apr 9. pii: 10.1245/s10434-022-11684.
    PubMed     Abstract available


  147. HUANG CC, Tseng LM
    ASO Author Reflections: Broaden the Targeted Population of Synthetic Lethality for Taiwanese Breast Cancer.
    Ann Surg Oncol. 2022 Apr 7. pii: 10.1245/s10434-022-11407.
    PubMed     Abstract available


  148. MINAMI CA, Jin G, Schonberg MA, Freedman RA, et al
    Variation in Deescalated Axillary Surgical Practices in Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 6. pii: 10.1245/s10434-022-11677.
    PubMed     Abstract available


  149. CROWN A, Ramiah K, Siegel B, Joseph KA, et al
    ASO Visual Abstract: The Role of Safety Net Hospitals in Reducing Disparities in Breast Cancer Care.
    Ann Surg Oncol. 2022 Apr 6. pii: 10.1245/s10434-022-11694.
    PubMed    


  150. BREDBECK BC, Mott NM, Wang T, Sinco BR, et al
    Facility-Level Variation of Low-Value Breast Cancer Treatments in Older Women with Early-Stage Breast Cancer: Analysis of a Statewide Claims Registry.
    Ann Surg Oncol. 2022 Apr 5. pii: 10.1245/s10434-022-11631.
    PubMed     Abstract available


  151. WHITWORTH P, Beitsch PD, Pellicane JV, Baron PL, et al
    Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2022 Apr 4. pii: 10.1245/s10434-022-11666.
    PubMed     Abstract available


  152. GUI Y, Chen Q, Li S, Yang X, et al
    ASO Visual Abstract: Safety and feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer-A Single-Center Retrospective Study.
    Ann Surg Oncol. 2022 Apr 3. pii: 10.1245/s10434-022-11449.
    PubMed    


  153. LE BLANC J, Golshan M, Lannin D, Greenup R, et al
    Association of Medicaid Expansion with Post-mastectomy Reconstruction Rates.
    Ann Surg Oncol. 2022;29:2181-2189.
    PubMed     Abstract available


  154. REGIS C, Le Deley MC, Bogart E, Leguillette C, et al
    Functional Cerebral MRI Evaluation of Integration of Breast Reconstruction into the Body Schema.
    Ann Surg Oncol. 2022;29:2652-2661.
    PubMed     Abstract available


  155. MOHAN SC, Tseng J, Marumoto A, Angarita S, et al
    Upstaging of Fibroepithelial Lesions: A Single-Institution Experience.
    Ann Surg Oncol. 2022;29:2193-2199.
    PubMed     Abstract available


  156. KARZAI S, Port E, Siderides C, Valente C, et al
    Impact of Screening Mammography on Treatment in Young Women Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2022 Apr 1. pii: 10.1245/s10434-022-11581.
    PubMed     Abstract available


  157. MOHAN SC, Tseng J, Marumoto A, Angarita S, et al
    ASO Visual Abstract: Upstaging of Fibroepithelial Lesions-A Single-Institution Experience.
    Ann Surg Oncol. 2022;29:2201.
    PubMed    


  158. LE BLANC J, Park T, Lannin D
    ASO Author Reflections: Despite Medicaid Expansion, Large Disparities in Breast Reconstruction Persist.
    Ann Surg Oncol. 2022;29:2190.
    PubMed    


    March 2022
  159. CROWN A, Ramiah K, Siegel B, Joseph KA, et al
    The Role of Safety-Net Hospitals in Reducing Disparities in Breast Cancer Care.
    Ann Surg Oncol. 2022 Mar 31. pii: 10.1245/s10434-022-11576.
    PubMed     Abstract available


  160. CROWN A, Joseph KA
    ASO Author Reflections: Reinforcing the Safety Net: Supporting Safety-Net Hospitals in Mitigating Breast Cancer Disparities.
    Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11640.
    PubMed    


  161. SONG JH, Kantor O, Mittendorf EA, King TA, et al
    Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Mar 30. pii: 10.1245/s10434-022-11543.
    PubMed     Abstract available


  162. BURKBAUER L, Goldbach M, Hoffman DI, Giannakou A, et al
    Preoperative MRI and Its Impact on Surgical Outcomes in Patients with Triple Negative Breast Cancer Treated with Primary Surgery: Did New Margin Guidelines or Cavity Shave Margins Practice Diminish the Role of Preoperative MRI?
    Ann Surg Oncol. 2022 Mar 18. pii: 10.1245/s10434-022-11545.
    PubMed     Abstract available


  163. FRIEDMAN-ELDAR O, Ozmen T, El Haddi SJ, Goel N, et al
    Axillary Response to Neoadjuvant Therapy in Node-Positive, Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients: Predictors and Oncologic Outcomes.
    Ann Surg Oncol. 2022 Mar 18. pii: 10.1245/s10434-022-11473.
    PubMed     Abstract available


  164. FRIEDMAN-ELDAR O, Ozmen T, Haddi SJE, Goel N, et al
    ASO Visual Abstract: Axillary Response to Neoadjuvant Therapy in Node-Positive ER+/HER2- Breast Cancer Patients-Predictors and Oncologic Outcomes.
    Ann Surg Oncol. 2022 Mar 14. pii: 10.1245/s10434-022-11531.
    PubMed    


  165. RING A, Campo D, Porras TB, Kaur P, et al
    Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Mar 8. pii: 10.1245/s10434-022-11589.
    PubMed    


  166. VERDIAL FC, Mamtani A, Pawloski KR, Sevilimedu V, et al
    The Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Mar 5. pii: 10.1245/s10434-022-11367.
    PubMed     Abstract available


  167. JIWA N, Kumar S, Gandhewar R, Chauhan H, et al
    Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature.
    Ann Surg Oncol. 2022;29:1774-1786.
    PubMed     Abstract available


  168. VICINI E, Leonardi MC, Fontana SKR, Pagan E, et al
    How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes.
    Ann Surg Oncol. 2022;29:1750-1760.
    PubMed     Abstract available


  169. ESGUEVA AJ, Noordhoek I, Kranenbarg EM, Espinosa-Bravo M, et al
    Health-Related Quality of Life After Nipple-Sparing Mastectomy: Results From the INSPIRE Registry.
    Ann Surg Oncol. 2022;29:1722-1734.
    PubMed     Abstract available


  170. MATAR R, Sevilimedu V, Park A, King TA, et al
    Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation.
    Ann Surg Oncol. 2022;29:1670-1679.
    PubMed     Abstract available


  171. WILLIAMS AD, Chang C, Sigurdson ER, Wang CH, et al
    Neoadjuvant Endocrine Therapy and Delays in Surgery for Ductal Carcinoma in Situ: Implications for the Coronavirus Pandemic.
    Ann Surg Oncol. 2022;29:1683-1691.
    PubMed     Abstract available


  172. WANG W, Shen Z, Zhang J, Chen H, et al
    A Novel Criterion for Lymph Nodes Dissection in Distal Pancreatectomy for Ductal Adenocarcinoma: A Population Study of the US SEER Database.
    Ann Surg Oncol. 2022;29:1533-1539.
    PubMed     Abstract available


  173. LAWS A, Katlin F, Nakhlis F, Chikarmane SA, et al
    Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision.
    Ann Surg Oncol. 2022;29:1660-1667.
    PubMed     Abstract available


  174. SOEGAARD BALLESTER JM, Goodsell KE, Ermer JP, Karakousis GC, et al
    New Operative Reporting Standards: Where We Stand Now and Opportunities for Innovation.
    Ann Surg Oncol. 2022;29:1797-1804.
    PubMed     Abstract available


  175. JIWA N, Leff D
    ASO Authors Reflection: Diagnostic Accuracy of Nipple Discharge Fluid Cytology: A Meta-Analysis and Systematic Review of the Literature.
    Ann Surg Oncol. 2022;29:1787-1788.
    PubMed    


  176. VICINI E, Fontana SKR, Leonardi MC, Veronesi P, et al
    ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
    Ann Surg Oncol. 2022;29:1761-1762.
    PubMed    


  177. PAWLOSKI KR, Moo TA
    ASO Author Reflection: Pain Control Can Be Optimized with Surgeon-Administered Local Anesthesia in Patients Undergoing Lumpectomy and Sentinel Lymph Node Biopsy with Multimodal Analgesia.
    Ann Surg Oncol. 2022;29:1746-1747.
    PubMed    


  178. MATAR R, Pilewskie M
    ASO Author Reflections: Observation After a Core Biopsy Diagnosis of Classic-Type LCIS Is a Safe Standard of Practice.
    Ann Surg Oncol. 2022;29:1680-1681.
    PubMed    


  179. WANG W, Shen B
    ASO Author Reflections: Lymphadenectomy in Distal Pancreatectomy for Ductal Adenocarcinoma: How to Do Better?
    Ann Surg Oncol. 2022;29:1540-1541.
    PubMed    


  180. ROSSI AJ, Verbus EA, Horst K, De Martini W, et al
    Surgical Excision Versus Neoadjuvant Radiotherapy Followed by Delayed Surgical Excision of Ductal Carcinoma In Situ (NORDIS).
    Ann Surg Oncol. 2022;29:1528-1529.
    PubMed    


    February 2022
  181. DUMITRU D, Ghanakumar S, Provenzano E, Benson JR, et al
    ASO Visual Abstract: A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (Sln) Detection in Early Breast Cancer.
    Ann Surg Oncol. 2022 Feb 21. pii: 10.1245/s10434-021-11313.
    PubMed    


  182. VERDIAL FC, Mamtani A, Pawloski KR, Sevilimedu V, et al
    ASO Visual Abstract: Effect of Age on Outcomes After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2022 Feb 20. pii: 10.1245/s10434-022-11425.
    PubMed    


  183. GUI Y, Chen Q, Chen L
    ASO Author Reflections: Minimally Invasive Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction for Early Breast Cancer.
    Ann Surg Oncol. 2022 Feb 18. pii: 10.1245/s10434-022-11422.
    PubMed    


  184. GUI Y, Chen Q, Li S, Yang X, et al
    Safety and Feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer: A Single-Center Retrospective Study.
    Ann Surg Oncol. 2022 Feb 16. pii: 10.1245/s10434-022-11420.
    PubMed     Abstract available


  185. CARMONA CA, Yee S, Seminsky M, Glass K, et al
    ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer.
    Ann Surg Oncol. 2022 Feb 15. pii: 10.1245/s10434-022-11340.
    PubMed    


  186. COBB AN, Adesoye T, Teshome M
    Progress and Persistent Challenges in Improving Care for Low-Income Women with Breast Cancer.
    Ann Surg Oncol. 2022 Feb 12. pii: 10.1245/s10434-022-11343.
    PubMed    


  187. MATAR R, Barrio AV, Sevilimedu V, Le T, et al
    ASO Visual Abstract: Can We Successfully Deescalate Axillary Surgery in Women Aged >/= 70 Years with Ductal Carcinoma In Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
    Ann Surg Oncol. 2022 Feb 3. pii: 10.1245/s10434-021-11305.
    PubMed    


  188. BAE J, Jeon BJ, Mun GH, Bang SI, et al
    Predictors for Implant Rupture in Two-Stage Tissue Expander-Based Breast Reconstruction: A Retrospective Cohort Study.
    Ann Surg Oncol. 2022;29:1100-1108.
    PubMed     Abstract available


  189. MAMTANI A, Sevilimedu V, Vincent A, Morrow M, et al
    Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers.
    Ann Surg Oncol. 2022;29:1043-1048.
    PubMed     Abstract available


  190. KELLY BN, Faulkner HR, Smith BL, Korotkin JE, et al
    Nipple-Sparing Mastectomy versus Skin-Sparing Mastectomy: Does Saving the Nipple Impact Short- and Long-Term Patient Satisfaction?
    Ann Surg Oncol. 2022;29:1033-1040.
    PubMed     Abstract available


  191. ERDRICH J, Cordova-Marks F, Monetathchi AR, Wu M, et al
    Disparities in Breast-Conserving Therapy for Non-Hispanic American Indian/Alaska Native Women Compared with Non-Hispanic White Women.
    Ann Surg Oncol. 2022;29:1019-1030.
    PubMed     Abstract available


  192. KANTOR O, Means J, Grossmith S, Dey T, et al
    Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes.
    Ann Surg Oncol. 2022;29:972-980.
    PubMed     Abstract available


  193. SHAMMAS RL, Fish LJ, Sergesketter AR, Offodile AC 2nd, et al
    Dissatisfaction After Post-Mastectomy Breast Reconstruction: A Mixed-Methods Study.
    Ann Surg Oncol. 2022;29:1109-1119.
    PubMed     Abstract available


  194. ERDRICH J
    ASO Author Reflections: Mastectomy Versus Lumpectomy: Are There Surgical Disparities for Native American Women Compared with White Women?
    Ann Surg Oncol. 2022;29:1031-1032.
    PubMed    


  195. MAMTANI A, Morrow M
    ASO Author Reflections: Heroic Mastectomy for Chemoresistant Disease: A Complex Decision.
    Ann Surg Oncol. 2022;29:1049-1050.
    PubMed    


  196. MONTAGNA G, Weber WP, Geroldinger A, Fitzal F, et al
    ASO Author Reflections: Impact of Resection Volume on Risk of Local Recurrence-The OPBC-01/iTOP2 Study.
    Ann Surg Oncol. 2022;29:1071-1072.
    PubMed    


  197. SHAMMAS RL, Greenup RA, Hollenbeck ST
    ASO Author Reflections: Decision Support Tools Are Needed to Address Dissatisfaction Among Women Seeking Post-Mastectomy Breast Reconstruction.
    Ann Surg Oncol. 2022;29:1120-1121.
    PubMed    


    January 2022
  198. KHAN SY, Melkus MW, Rasha F, Castro M, et al
    Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-021-11157.
    PubMed     Abstract available


  199. MATHEW AT, Jain B, Dee EC, Johnson J, et al
    Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.
    Ann Surg Oncol. 2022 Jan 29. pii: 10.1245/s10434-022-11349.
    PubMed    


  200. KHAN SY, Melkus MW, Rasha F, Castro M, et al
    ASO Visual Abstract: Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer-A Pilot Study.
    Ann Surg Oncol. 2022 Jan 25. pii: 10.1245/s10434-021-11240.
    PubMed    


  201. NAFFOUJE SA, Barker V, Lee MC, Hoover SJ, et al
    ASO Visual Abstract: Surgical Management of the Axilla of Triple-Negative Breast Cancer in the Z1071 Era-A Propensity-Score Matched Analysis of the National Cancer Database.
    Ann Surg Oncol. 2022 Jan 25. pii: 10.1245/s10434-021-11281.
    PubMed    


  202. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
    ASO Visual Abstract: Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Ann Surg Oncol. 2022 Jan 21. pii: 10.1245/s10434-021-11178.
    PubMed    


  203. DUCHESNEAU ED, An SJ, Strassle PD, Reeder-Hayes KE, et al
    Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
    Ann Surg Oncol. 2022 Jan 17. pii: 10.1245/s10434-021-11260.
    PubMed     Abstract available


  204. GUAY E, Cordeiro E, Roberts A
    ASO Visual Abstract: Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.
    Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11246.
    PubMed    


  205. LUDWIGSON A, Huynh V, Myers S, Hampanda K, et al
    ASO Visual Abstract: Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed-Methods Study.
    Ann Surg Oncol. 2022 Jan 16. pii: 10.1245/s10434-021-11256.
    PubMed    


  206. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
    ASO Visual Abstract: The Breast Cancer Patient Experience of Telemedicine During COVID-19.
    Ann Surg Oncol. 2022 Jan 14. pii: 10.1245/s10434-021-11183.
    PubMed    


  207. LIN SQ, Vo NP, Yen YC, Tam KW, et al
    ASO Visual Abstract: Outcomes of Sentinel Node Biopsy in Women with Breast Cancer Following Neoadjuvant Therapy-Systematic Review and Meta-Analysis of Real-World Data.
    Ann Surg Oncol. 2022 Jan 13. pii: 10.1245/s10434-021-11306.
    PubMed    


  208. DUCHESNEAU ED, An SJ, Strassle PD, Reeder-Hayes K, et al
    ASO Visual Abstract: Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.
    Ann Surg Oncol. 2022 Jan 12. pii: 10.1245/s10434-021-11312.
    PubMed    


  209. KONISHI T, Fujiogi M, Sato A, Michihata N, et al
    ASO Visual Abstract: Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.
    Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11272.
    PubMed    


  210. LIN SQ, Vo NP, Yen YC, Tam KW, et al
    Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data.
    Ann Surg Oncol. 2022 Jan 11. pii: 10.1245/s10434-021-11297.
    PubMed     Abstract available


  211. NAFFOUJE SA, Barker V, Lee MC, Hoover SJ, et al
    Surgical Management of Axilla of Triple-Negative Breast Cancer in the Z1071 Era: A Propensity Score-Matched Analysis of the National Cancer Database.
    Ann Surg Oncol. 2022 Jan 10. pii: 10.1245/s10434-021-11194.
    PubMed     Abstract available


  212. CARMONA CA, Yee S, Seminsky M, Glass K, et al
    Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer.
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11254.
    PubMed     Abstract available


  213. OBENG-GYASI S, Rose J, Dong W, Kim U, et al
    ASO Visual Abstract: Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11172.
    PubMed    


  214. RING A, Campo D, Porras TB, Kaur P, et al
    Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Jan 9. pii: 10.1245/s10434-021-11135.
    PubMed     Abstract available


  215. DUMITRU D, Ghanakumar S, Provenzano E, Benson JR, et al
    A Prospective Study Evaluating the Accuracy of Indocyanine Green (ICG) Fluorescence Compared with Radioisotope for Sentinel Lymph Node (SLN) Detection in Early Breast Cancer.
    Ann Surg Oncol. 2022 Jan 8. pii: 10.1245/s10434-021-11255.
    PubMed     Abstract available


  216. KONISHI T, Fujiogi M, Tanabe M, Seto Y, et al
    ASO Author Reflections: Neoadjuvant Chemotherapy Does Not Affect Short-Term Outcomes After Breast Cancer Surgery.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11277.
    PubMed    


  217. KONISHI T, Fujiogi M, Sato A, Michihata N, et al
    Short-Term Outcomes Following Breast Cancer Surgery With and Without Neoadjuvant Chemotherapy: A Nationwide Administrative Database Study in Japan.
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11212.
    PubMed     Abstract available


  218. MOORMAN AM, Rutgers EJT, Kouwenhoven EA
    ASO Visual Abstract: Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11130.
    PubMed    


  219. MATAR R, Barrio AV, Sevilimedu V, Le T, et al
    Can We Successfully De-Escalate Axillary Surgery in Women Aged >/= 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy?
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-11140.
    PubMed     Abstract available


  220. MATAR R, Crown A, Sevilimedu V, Goldfarb SB, et al
    ASO Visual Abstract: Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
    Ann Surg Oncol. 2022 Jan 7. pii: 10.1245/s10434-021-10971.
    PubMed    


  221. TAMIRISA N, Hunt KK
    Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11223.
    PubMed    


  222. CARMONA C, Warner E
    ASO Author Reflections: Referring Young Breast Cancer Patients for Fertility Preservation: Significant Progress but Still Room for Improvement.
    Ann Surg Oncol. 2022 Jan 6. pii: 10.1245/s10434-021-11288.
    PubMed    


  223. PLICHTA JK
    Circulating Tumor Cells and Breast Cancer: The Long and Winding Road Behind and Before Us.
    Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11301.
    PubMed    


  224. RING A, Campo D, Porras TB, Kaur P, et al
    ASO Visual Abstract: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer.
    Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11216.
    PubMed    


  225. CORDEIRO E, Guay E, Roberts A
    ASO Author Reflections: Improving Efficiency of Care for Young Women with Breast Cancer.
    Ann Surg Oncol. 2022 Jan 4. pii: 10.1245/s10434-021-11164.
    PubMed    


  226. DIETZ JR
    Editorial: Impact of the Covid-19 Pandemic on Breast Cancer Treatment and Patient Experience.
    Ann Surg Oncol. 2022 Jan 2. pii: 10.1245/s10434-021-11227.
    PubMed    


  227. DE LORENZI F, Borelli F, Pagan E, Bagnardi V, et al
    Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis.
    Ann Surg Oncol. 2022;29:427-436.
    PubMed     Abstract available


  228. GANESH KUMAR N, Berlin NL, Hawley ST, Jagsi R, et al
    Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy.
    Ann Surg Oncol. 2022;29:535-544.
    PubMed     Abstract available


  229. GURAM S, Covelli AM, O'Neill AC, Shultz DB, et al
    Multidisciplinary Intervention in Radiation-Associated Angiosarcoma of the Breast: Patterns of Recurrence and Response to Treatment.
    Ann Surg Oncol. 2022;29:522-532.
    PubMed     Abstract available


  230. BOGACH J, Shakeel S, Wright FC, Hong NJL, et al
    Phyllodes Tumors: A Scoping Review of the Literature.
    Ann Surg Oncol. 2022;29:446-459.
    PubMed     Abstract available


  231. SAHAKYAN MA, Verbeke CS, Tholfsen T, Ignjatovic D, et al
    Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2022;29:366-375.
    PubMed     Abstract available


  232. DE LORENZI F, Borelli F
    ASO Author Reflections: The Safety of Oncoplastic Surgery for Multicentric and Multifocal Breast Tumors.
    Ann Surg Oncol. 2022;29:437.
    PubMed    


  233. MATROS E, Offodile AC 2nd
    Financial Toxicity Following Post-Mastectomy Reconstruction: Consideration for a Novel Outcome Measure.
    Ann Surg Oncol. 2022;29:25-27.
    PubMed    


  234. GANESH KUMAR N, Momoh AO
    ASO Author Reflections: Characterizing Financial Toxicity in Post-mastectomy Breast Reconstruction: A Need for Additional Perspectives.
    Ann Surg Oncol. 2022;29:545-546.
    PubMed    


  235. SUN SX, Suk R, Kuerer HM, Cantor SB, et al
    No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2022;29:39-41.
    PubMed    


  236. COVELLI AM, Gladdy RA
    ASO Author Reflections: Rethinking Radiation Associated Angiosarcoma of the Breast-Secondary Malignancies That Require Expert Care for Improved Outcomes.
    Ann Surg Oncol. 2022;29:533-534.
    PubMed    


  237. SAHAKYAN MA, Labori KJ, Edwin B
    ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma-Does Surgery Tell the Whole Story?
    Ann Surg Oncol. 2022;29:376-377.
    PubMed    


    December 2021
  238. LUDWIGSON A, Huynh V, Myers S, Hampanda K, et al
    Patient Perceptions of Changes in Breast Cancer Care and Well-Being During COVID-19: A Mixed Methods Study.
    Ann Surg Oncol. 2021 Dec 20. pii: 10.1245/s10434-021-11209.
    PubMed     Abstract available


  239. KING CA, Bartholomew AJ, Sosin M, Avila A, et al
    A Critical Appraisal of Late Complications of Prepectoral versus Subpectoral Breast Reconstruction Following Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2021;28:9150-9158.
    PubMed     Abstract available


  240. ZHANG X, Liu W, Hai T, Li F, et al
    Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.
    Ann Surg Oncol. 2021;28:8643-8650.
    PubMed     Abstract available


  241. MURPHY BM, Hoskin TL, Degnim AC, Boughey JC, et al
    Surgical Management of Axilla Following Neoadjuvant Endocrine Therapy.
    Ann Surg Oncol. 2021;28:8729-8739.
    PubMed     Abstract available


  242. JAMES TA, Fan B
    ASO Author Reflections: National Analysis of Breast Surgery Malpractice Cases: A Teachable Moment?
    Ann Surg Oncol. 2021;28:8116-8117.
    PubMed    


  243. LEE SE, Kim HY, Yoon JH, Kim EK, et al
    Chronological Trends of Breast Ductal Carcinoma In Situ: Clinical, Radiologic, and Pathologic Perspectives.
    Ann Surg Oncol. 2021;28:8699-8709.
    PubMed     Abstract available


  244. HUYNH V, Yang J, Bronsert M, Ludwigson A, et al
    Choosing Between Mastectomy and Breast-Conserving Therapy: Is Patient Distress an Influencing Factor?
    Ann Surg Oncol. 2021;28:8679-8687.
    PubMed     Abstract available


  245. FAN B, Pardo J, Yu-Moe CW, Janes M, et al
    Malpractice Cases in Breast Surgery: An Assessment of Litigation Involving Surgeons.
    Ann Surg Oncol. 2021;28:8109-8115.
    PubMed     Abstract available


  246. RING A, Lang JE
    ASO Author Reflections: Advancing Circulating Tumor Cells as Liquid Biopsies to Efficiently Target Metastatic Breast Cancer.
    Ann Surg Oncol. 2021 Dec 1. pii: 10.1245/s10434-021-11139.
    PubMed    


  247. ZHANG X, Liu W, Hai T, Li F, et al
    ASO Visual Abstract: Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-analysis.
    Ann Surg Oncol. 2021;28.
    PubMed     Abstract available


  248. BOGACH J, Shakeel S, Wright FC, Hong NJL, et al
    ASO Visual Abstract: Phyllodes Tumors: A Scoping Review of the Literature.
    Ann Surg Oncol. 2021;28.
    PubMed    


  249. HUYNH V, Yang J, Bronsert M, Ludwigson A, et al
    ASO Visual Abstract: Choosing Between Mastectomy and Breast-Conserving Therapy-Is Patient Distress an Influencing Factor?
    Ann Surg Oncol. 2021;28.
    PubMed    


  250. STAHL K, Wong W, Dodge D, Brooks A, et al
    ASO Visual Abstract: Benefits of Surgical Treatment in Stage IV Breast Cancer in Patients with Known Hormone Receptor and HER2 Status.
    Ann Surg Oncol. 2021;28.
    PubMed    


  251. ROSENBERGER LH, Quintana LM, Thomas SM, Nimbkar SN, et al
    ASO Visual Abstract: Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
    Ann Surg Oncol. 2021;28.
    PubMed    


  252. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
    ASO Visual Abstract: Surgical decision-making surrounding contralateral prophylactic mastectomy-- Comparison of treatment goals, preferences, and psychosocial outcomes from a multi-center survey of breast cancer patients.
    Ann Surg Oncol. 2021;28.
    PubMed     Abstract available


  253. PAWLOSKI KR, El-Tamer M
    Reply to Significance of 21-Gene Nonconcordant Recurrence Scores in Patients with Multifocal or Multicentric Breast Carcinomas.
    Ann Surg Oncol. 2021;28.
    PubMed    


  254. SORSCHER S
    Significance of 21-Gene Non-Concordant Recurrence Scores in Patients with Multifocal or Multicentric Breast Carcinomas.
    Ann Surg Oncol. 2021;28.
    PubMed    


  255. ALTUNDAG K
    Specific Histological Subgroups in Invasive Lobular Carcinoma Might Affect Management Strategy in Invasive Lobular Carcinoma of the Breast.
    Ann Surg Oncol. 2021;28.
    PubMed    


  256. MCCORMICK PJ, Assel M, Van Zee KJ, Vickers AJ, et al
    Reply to: "Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?"
    Ann Surg Oncol. 2021;28.
    PubMed    


  257. LI L, Zhao X, Xiang B, Tang X, et al
    Ketorolac following Mastectomy: Is There an Increased Risk of Reoperation?
    Ann Surg Oncol. 2021;28.
    PubMed    


  258. GIULIANO AE, Vane M
    Reply to Comment on: "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".
    Ann Surg Oncol. 2021;28.
    PubMed    


  259. CORTINA CS, Kong AL
    Comment on "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".
    Ann Surg Oncol. 2021;28.
    PubMed    


  260. JAMES TA, Zhang JQ
    ASO Author Reflections: Addressing the Early Onset of Clinical Practice Distress in Breast Surgery.
    Ann Surg Oncol. 2021;28.
    PubMed    


  261. CORSO G
    Second Reply to: "Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?"
    Ann Surg Oncol. 2021;28.
    PubMed    


    November 2021
  262. TONNESON JE, Boughey JC
    ASO Author Reflections: How COVID-19 Impacted Breast Cancer Presentation and Management.
    Ann Surg Oncol. 2021 Nov 30. pii: 10.1245/s10434-021-11098.
    PubMed    


  263. OBENG-GYASI S, Rose J, Koroukian S
    ASO Author Reflections: Medicaid Expansion is Key in Mitigating Surgical Disparities in Low-Income Breast Cancer Patients.
    Ann Surg Oncol. 2021 Nov 27. pii: 10.1245/s10434-021-11138.
    PubMed    


  264. OBENG-GYASI S, Rose J, Dong W, Kim U, et al
    Is Medicaid Expansion Narrowing Gaps in Surgical Disparities for Low-Income Breast Cancer Patients?
    Ann Surg Oncol. 2021 Nov 27. pii: 10.1245/s10434-021-11137.
    PubMed     Abstract available


  265. GUAY E, Cordeiro E, Roberts A
    Young Women with Breast Cancer: Chemotherapy or Surgery First? An Evaluation of Time to Treatment for Invasive Breast Cancer.
    Ann Surg Oncol. 2021 Nov 26. pii: 10.1245/s10434-021-11102.
    PubMed     Abstract available


  266. KOELBEL V, Pfob A, Schaefgen B, Sinn P, et al
    ASO Visual Abstract: Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment to Reliably Exclude Residual Cancer in Breast Cancer Patients.
    Ann Surg Oncol. 2021 Nov 26. pii: 10.1245/s10434-021-10958.
    PubMed    


  267. MITTAL A, Deo S, Gogia A, Batra A, et al
    ASO Visual Abstract: Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
    Ann Surg Oncol. 2021 Nov 25. pii: 10.1245/s10434-021-10967.
    PubMed    


  268. CADILI L, DeGirolamo K, Ma CS, Chen L, et al
    The Breast Cancer Patient Experience of Telemedicine During COVID-19.
    Ann Surg Oncol. 2021 Nov 24. pii: 10.1245/s10434-021-11103.
    PubMed     Abstract available


  269. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
    ASO Visual Abstract: A Single Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11038.
    PubMed    


  270. TONNESON JE, Hoskin TL, Day CN, Durgan DM, et al
    Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Ann Surg Oncol. 2021 Nov 23. pii: 10.1245/s10434-021-11088.
    PubMed     Abstract available


  271. FU M, Chen Q, Zeng L, Hong T, et al
    Prognosis Comparison Between Nipple-Sparing Mastectomy and Total Mastectomy in Breast Cancer: A Case-Control Study After Propensity Score Matching.
    Ann Surg Oncol. 2021 Nov 20. pii: 10.1245/s10434-021-11044.
    PubMed     Abstract available


  272. MATAR R, Gemignani ML
    ASO Author Reflections: Stage IV Pregnancy-Associated Breast Cancer: A Continuum of Disease.
    Ann Surg Oncol. 2021 Nov 19. pii: 10.1245/s10434-021-11018.
    PubMed    


  273. VERBUS EA, Rossi AJ, Clark AS, Taunk NK, et al
    Preoperative Use of a Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer.
    Ann Surg Oncol. 2021 Nov 16. pii: 10.1245/s10434-021-10987.
    PubMed    


  274. SARIDAKIS A, Berger ER, Greenup R, Golshan M, et al
    ASO Author Reflections: Apocrine Breast Cancer: More Questions than Answers.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10649.
    PubMed    


  275. ELMORE LC, Kuerer HM, Barcenas CH, Smith BD, et al
    ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10579.
    PubMed    


  276. ADESOYE T, Babayemi O, Postlewait LM, DeSnyder SM, et al
    ASO Visual Abstract: Inflammatory Breast Cancer at the Extremes of Age.
    Ann Surg Oncol. 2021 Nov 6. pii: 10.1245/s10434-021-10586.
    PubMed    


  277. MOORMAN AM, Rutgers EJT, Kouwenhoven EA
    Omitting SLNB in Breast Cancer: Is a Nomogram the Answer?
    Ann Surg Oncol. 2021 Nov 5. pii: 10.1245/s10434-021-11007.
    PubMed     Abstract available


  278. BHUTIANI N, Holland MM, Mercer MK, Donaldson M, et al
    Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost.
    Ann Surg Oncol. 2021;28:7432-7438.
    PubMed     Abstract available


  279. KLASSEN AF, Kaur MN, Tsangaris E, de Vries CEE, et al
    Development and Psychometric Validation of BREAST-Q Scales Measuring Cancer Worry, Fatigue, and Impact on Work.
    Ann Surg Oncol. 2021;28:7410-7420.
    PubMed     Abstract available


  280. ROSENBERGER LH, Quintana LM, Thomas SM, Nimbkar SN, et al
    Limited Reporting of Histopathologic Details in a Multi-Institutional Academic Cohort of Phyllodes Tumors: Time for Standardization.
    Ann Surg Oncol. 2021;28:7404-7409.
    PubMed     Abstract available


  281. TSANGARIS E, Klassen AF, Kaur MN, Voineskos S, et al
    Development and Psychometric Validation of the BREAST-Q Sensation Module for Women Undergoing Post-Mastectomy Breast Reconstruction.
    Ann Surg Oncol. 2021;28:7842-7853.
    PubMed     Abstract available


  282. LAI HW
    ASO Author Reflections: Oncologic Outcome of Endoscopic-Assisted Breast Surgery Compared with the Conventional Approach in Breast Cancers.
    Ann Surg Oncol. 2021;28:7381-7382.
    PubMed    


  283. BHUTIANI N, Ajkay N
    ASO Author Reflections: The Broad Impact of the Margin Consensus Guidelines for Breast-Conserving Surgery in DCIS.
    Ann Surg Oncol. 2021;28:7439-7440.
    PubMed    


  284. CHAGPAR AB
    Guide to Enhanced Recovery for Cancer Patients Undergoing Breast Surgery and Reconstruction.
    Ann Surg Oncol. 2021;28:6943-6946.
    PubMed    


    October 2021
  285. MYERS SP, Ahrendt GM, Lee JS, Steiman J, et al
    ASO Visual Abstract: Association of Tumor Molecular Subtype and Stage with Breast and Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Oct 29. pii: 10.1245/s10434-021-10255.
    PubMed    


  286. MILLEN EC, Cavalcante FP, Zerwes F, Novita G, et al
    ASO Visual Abstract: The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer 10 Years After the ACOSOG Z0011 Trial First Publication.
    Ann Surg Oncol. 2021 Oct 28. pii: 10.1245/s10434-021-10939.
    PubMed    


  287. MATAR R, Crown A, Sevilimedu V, Goldfarb SB, et al
    Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC).
    Ann Surg Oncol. 2021 Oct 28. pii: 10.1245/s10434-021-10901.
    PubMed     Abstract available


  288. ASCHA M, Felt D, Beach LB, Kulkarni SA, et al
    ASO Author Reflections: Constructing a Transgender and Nonbinary Cohort to Analyze Breast Cancer Screening.
    Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10978.
    PubMed    


  289. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Visual Abstract: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates Among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 27. pii: 10.1245/s10434-021-10942.
    PubMed    


  290. LUEHMANN N, Ascha M, Chwa E, Hackenberger P, et al
    A Single-Center Study of Adherence to Breast Cancer Screening Mammography Guidelines by Transgender and Non-Binary Patients.
    Ann Surg Oncol. 2021 Oct 26. pii: 10.1245/s10434-021-10932.
    PubMed     Abstract available


  291. FITZAL F, Bolliger M, Dunkler D, Geroldinger A, et al
    ASO Visual Abstract: Retrospective Multicenter Analysis Comparing Conventional with Oncoplastic Breast-Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
    Ann Surg Oncol. 2021 Oct 21. pii: 10.1245/s10434-021-10898.
    PubMed    


  292. KHAN TM, Rossi AJ, Suman V, Haffty B, et al
    Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2021 Oct 20. pii: 10.1245/s10434-021-10830.
    PubMed    


  293. STAHL K, Dodge D, Shen C
    Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit: Author's Reply.
    Ann Surg Oncol. 2021 Oct 18. pii: 10.1245/s10434-021-10906.
    PubMed    


  294. HERREMANS KM, Cribbin MP, Riner AN, Neal DW, et al
    ASO Visual Abstract: A 5-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Ann Surg Oncol. 2021 Oct 16. pii: 10.1245/s10434-021-10648.
    PubMed    


  295. MITTAL A, Pramanik R
    ASO Author Reflections: Germline Testing for All Patients With Breast Cancer: Has the Time Finally Come?
    Ann Surg Oncol. 2021 Oct 15. pii: 10.1245/s10434-021-10880.
    PubMed     Abstract available


  296. FITZAL F, Bolliger M, Dunkler D, Geroldinger A, et al
    Retrospective, Multicenter Analysis Comparing Conventional with Oncoplastic Breast Conserving Surgery: Oncological and Surgical Outcomes in Women with High-Risk Breast Cancer from the OPBC-01/iTOP2 Study.
    Ann Surg Oncol. 2021 Oct 13. pii: 10.1245/s10434-021-10809.
    PubMed     Abstract available


  297. MURALI-NANAVATI S, Nair NS, Badwe R
    Surgery of the Primary Tumor in De Novo Metastatic Breast Cancer Confers No Survival Benefit.
    Ann Surg Oncol. 2021 Oct 11. pii: 10.1245/s10434-021-10887.
    PubMed    


  298. DESNYDER SM, Yi M, Boccardo F, Feldman S, et al
    ASO Visual Abstract: American Society of Breast Surgeons Practice Patterns for Patients At-risk and Affected by Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Oct 9. pii: 10.1245/s10434-021-10608.
    PubMed    


  299. DELIERE A, Attai D, Victorson D, Kuchta K, et al
    ASO Visual Abstract: Decision Regret About Breast Cancer Surgery-The WhySurg Study: Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Found to Have Lowest Levels of Regret.
    Ann Surg Oncol. 2021 Oct 6. pii: 10.1245/s10434-021-10591.
    PubMed    


  300. OROZCO JIJ, Grumley JG
    ASO Author Reflections: Molecular Testing in Breast Cancer: Is Core Biopsy Equivalent to Surgical Specimen?
    Ann Surg Oncol. 2021 Oct 4. pii: 10.1245/s10434-021-10604.
    PubMed    


  301. MITTAL A, Deo SVS, Gogia A, Batra A, et al
    Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center.
    Ann Surg Oncol. 2021 Oct 2. pii: 10.1245/s10434-021-10870.
    PubMed     Abstract available


  302. CHAKEDIS JM, Tang A, Kuehner GE, Vuong B, et al
    Implementation of Intraoperative Ultrasound Localization for Breast-Conserving Surgery in a Large, Integrated Health Care System is Feasible and Effective.
    Ann Surg Oncol. 2021;28:5648-5656.
    PubMed     Abstract available


  303. DELIERE A, Attai D, Victorson D, Kuchta K, et al
    Patients Undergoing Bilateral Mastectomy and Breast-Conserving Surgery Have the Lowest Levels of Regret: The WhySurg Study.
    Ann Surg Oncol. 2021;28:5686-5697.
    PubMed     Abstract available


  304. ILES K, Strassle PD, Agala CB, Button J, et al
    Surgical Axillary Staging Before Neoadjuvant Chemotherapy: Who Gets It and Why We Should Avoid It.
    Ann Surg Oncol. 2021;28:5788-5797.
    PubMed     Abstract available


  305. KEDRZYCKI MS, Leiloglou M, Chalau V, Chiarini N, et al
    The Impact of Temporal Variation in Indocyanine Green Administration on Tumor Identification During Fluorescence Guided Breast Surgery.
    Ann Surg Oncol. 2021;28:5617-5625.
    PubMed     Abstract available


  306. ABBASSI-RAHBAR S, Sack S, Larson KE, Wagner JL, et al
    Multidisciplinary Review of Intraductal Papilloma of the Breast can Identify Patients who may Omit Surgical Excision.
    Ann Surg Oncol. 2021;28:5768-5774.
    PubMed     Abstract available


  307. CHAGPAR AB
    Debate: Postmastectomy Radiation Therapy in T1/2N1 Disease.
    Ann Surg Oncol. 2021;28:5456-5460.
    PubMed     Abstract available


  308. RAMALINGAM K, Ji L, Pairawan S, Molina DC, et al
    Improvement in Breast Reconstruction Disparities following Medicaid Expansion under the Affordable Care Act.
    Ann Surg Oncol. 2021;28:5558-5567.
    PubMed     Abstract available


  309. KOPKASH K, Novak K, Murphy R, Deliere A, et al
    Improving the Breast Surgeon's Ergonomic Workload for Nipple-Sparing Mastectomies Using Exercise and Operating Room Positioning Protocol.
    Ann Surg Oncol. 2021;28:5698-5706.
    PubMed     Abstract available


  310. SCHWARTZ JL, Kirkpatrick L, Hillebrecht KE, Lee JS, et al
    Cutting Instruments to Cut Costs: A Simple Initiative with Breast Surgical Operating Room Trays that Resulted in Substantial Savings.
    Ann Surg Oncol. 2021;28:5553-5557.
    PubMed     Abstract available


  311. ARMANI A, Douglas S, Kulkarni S, Wallace A, et al
    Controversial Areas in Axillary Staging: Are We Following the Guidelines?
    Ann Surg Oncol. 2021;28:5580-5587.
    PubMed     Abstract available


  312. ELSHERIF A, Cocco D, Armanyous S, Cummins A, et al
    Nipple-Sparing Mastectomy: Are We Providing Proper Prophylactic Antibiotic Coverage?
    Ann Surg Oncol. 2021;28:5486-5494.
    PubMed     Abstract available


  313. GARSTKA M, Henriquez A, Kelly BN, Webster A, et al
    How Protective are Nipple-Sparing Prophylactic Mastectomies in BRCA1 and BRCA2 Mutation Carriers?
    Ann Surg Oncol. 2021;28:5657-5662.
    PubMed     Abstract available


  314. JU T, Chandler J, Momeni A, Gurtner G, et al
    Two-Stage Versus One-Stage Nipple-Sparing Mastectomy: Timing of Surgery Prevents Nipple Loss.
    Ann Surg Oncol. 2021;28:5707-5715.
    PubMed     Abstract available


  315. CORTINA CS, Bergom C, Craft MA, Fields B, et al
    A National Survey of Breast Surgeons and Radiation Oncologists on Contemporary Axillary Management in Mastectomy Patients.
    Ann Surg Oncol. 2021;28:5568-5579.
    PubMed     Abstract available


  316. BUTLER PD, Morris MP, Momoh AO
    Persistent Disparities in Postmastectomy Breast Reconstruction and Strategies for Mitigation.
    Ann Surg Oncol. 2021;28:6099-6108.
    PubMed     Abstract available


  317. BYUN DJ, Wu SP, Nagar H, Gerber NK, et al
    Ductal Carcinoma in Situ in Young Women: Increasing Rates of Mastectomy and Variability in Endocrine Therapy Use.
    Ann Surg Oncol. 2021;28:6083-6096.
    PubMed     Abstract available


  318. MOO TA, Saccarelli CR, Sutton EJ, Sevilimedu V, et al
    Tumor-Nipple Distance of >/= 1 cm Predicts Negative Nipple Pathology After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2021;28:6024-6029.
    PubMed     Abstract available


  319. SHAH C, Bremer T, Cox C, Whitworth P, et al
    The Clinical Utility of DCISionRT((R)) on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery.
    Ann Surg Oncol. 2021;28:5974-5984.
    PubMed     Abstract available


  320. GORDON NT, Alberty-Oller JJ, Fei K, Greco G, et al
    Association of Insulin Resistance and Higher Oncotype DX Recurrence Score.
    Ann Surg Oncol. 2021;28:5941-5947.
    PubMed     Abstract available


  321. VAN LA PARRA RFD, Clough KB, Thygesen HH, Levy E, et al
    Oncological Safety of Oncoplastic Level II Mammoplasties After Neoadjuvant Chemotherapy for Large Breast Cancers: A Matched-Cohort Analysis.
    Ann Surg Oncol. 2021;28:5920-5928.
    PubMed     Abstract available


  322. HILLS N, Leslie M, Davis R, Crowell M, et al
    Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast Carcinoma.
    Ann Surg Oncol. 2021;28:5895-5905.
    PubMed     Abstract available


  323. MUKHTAR RA, Hoskin TL, Habermann EB, Day CN, et al
    Changes in Management Strategy and Impact of Neoadjuvant Therapy on Extent of Surgery in Invasive Lobular Carcinoma of the Breast: Analysis of the National Cancer Database (NCDB).
    Ann Surg Oncol. 2021;28:5867-5877.
    PubMed     Abstract available


  324. RELATION T, Obeng-Gyasi S, Bhattacharyya O, Li Y, et al
    Racial Differences in Response to Neoadjuvant Chemotherapy: Impact on Breast and Axillary Surgical Management.
    Ann Surg Oncol. 2021;28:6489-6497.
    PubMed     Abstract available


  325. ILES K, Downs-Canner S
    ASO Author Reflections: Use of Axillary Staging Surgery Before Systemic Therapy in Breast Cancer Highlights a Need for Implementation Science in Surgery.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10747.
    PubMed    


  326. MOO TA, Sacchini V
    ASO Author Reflections: Tumor-Nipple Distance of >/= 1 cm on Pre- or Post-Neoadjuvant Chemotherapy Imaging can be used to Determine Eligibility for Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2021;28:6030-6031.
    PubMed    


  327. WEISS A, Golshan M, Ollila DW
    ASO Author Reflections: Accurately Predicting Nodal pCR Holds the Key to Axillary Surgery De-escalation Strategies.
    Ann Surg Oncol. 2021;28:5972-5973.
    PubMed    


  328. GORDON N, Alberty-Oller J
    Genomic Assays and the Great Unknown: The Oncotype DX May Miss the Mark in Certain Populations.
    Ann Surg Oncol. 2021;28:5948-5949.
    PubMed    


  329. SCHWARTZ T
    Just Say No: The Case Against Opioid-Based Postoperative Pain Management Regimens Following Breast Surgery.
    Ann Surg Oncol. 2021;28:5799-5800.
    PubMed    


  330. ELDREDGE-HINDY H
    ASO Author Reflections: Five-Fraction Whole-Breast Radiation: Let's Make Adjuvant Therapy Accessible.
    Ann Surg Oncol. 2021;28:5893-5894.
    PubMed    


  331. MUKHTAR RA, Boughey JC
    ASO Author Reflections: Changes in Primary Treatment Strategy for Invasive Lobular Carcinoma Highlight the Need for Better Predictors of Therapy Response.
    Ann Surg Oncol. 2021;28:5878-5879.
    PubMed    


  332. HILLS N, Leslie M, Davis R, Crowell M, et al
    ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?
    Ann Surg Oncol. 2021;28:5906.
    PubMed    


  333. HERBERT C, Paro A, Diaz A, Pawlik TM, et al
    ASO Author Reflections: Association of Community Economic Distress and Breast and Colorectal Cancer Screening, Incidence, and Mortality Rates among U.S. Counties.
    Ann Surg Oncol. 2021 Oct 1. pii: 10.1245/s10434-021-10864.
    PubMed    


    September 2021
  334. BREDBECK BC, Dossett LA
    ASO Author Reflections: Adding up the Costs of Low-Value Breast Cancer Care.
    Ann Surg Oncol. 2021 Sep 29. pii: 10.1245/s10434-021-10863.
    PubMed    


  335. GONZALEZ L, Sun C, Loscalzo M, Clark K, et al
    A Cross-Sectional Study of Distress Levels in Patients with Newly Diagnosed Breast Cancer: The Impact of Race, Ethnicity, and Language Preference.
    Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10561.
    PubMed     Abstract available


  336. KOELBEL V, Pfob A, Schaefgen B, Sinn P, et al
    Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
    Ann Surg Oncol. 2021 Sep 28. pii: 10.1245/s10434-021-10847.
    PubMed     Abstract available


  337. MILLEN EC, Cavalcante FP, Zerwes F, Novita G, et al
    The Attitudes of Brazilian Breast Surgeons on Axillary Management in Early Breast Cancer-10 Years after the ACOSOG Z0011 Trial First Publication.
    Ann Surg Oncol. 2021 Sep 27. pii: 10.1245/s10434-021-10812.
    PubMed     Abstract available


  338. MILLEN EC, Cavalcante FP
    ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
    Ann Surg Oncol. 2021 Sep 24. pii: 10.1245/s10434-021-10836.
    PubMed    


  339. BREDBECK BC, Baskin AS, Wang T, Sinco BR, et al
    Incremental Spending Associated with Low-Value Treatments in Older Women with Breast Cancer.
    Ann Surg Oncol. 2021 Sep 23. pii: 10.1245/s10434-021-10807.
    PubMed     Abstract available


  340. NAGRA NS, Tsangaris E, Means J, Hassett MJ, et al
    Correction to: Time-Driven Activity-Based Costing in Breast Cancer Care Delivery.
    Ann Surg Oncol. 2021 Sep 21. pii: 10.1245/s10434-021-10795.
    PubMed    


  341. STAHL K, Dodge D, Wong W, Shen C, et al
    ASO Author Reflection: Trimodality Therapy Offers Survival Advantage in Metastatic Male Breast Cancer.
    Ann Surg Oncol. 2021 Sep 16. pii: 10.1245/s10434-021-10790.
    PubMed    


  342. ISHIZUKA Y, Horimoto Y
    Re: The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multicenter, Prospective Registry Study.
    Ann Surg Oncol. 2021 Sep 12. pii: 10.1245/s10434-021-10528.
    PubMed    


  343. BRUNELLE CL, Taghian AG
    ASO Author Reflections: Breast Cancer-Related Lymphedema-A Suggested Clinical Pathway for Diagnosis.
    Ann Surg Oncol. 2021 Sep 9. pii: 10.1245/s10434-021-10702.
    PubMed    


  344. KASSAMANI YW, Brunelle CL, Gillespie TC, Bernstein MC, et al
    Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement.
    Ann Surg Oncol. 2021 Sep 9. pii: 10.1245/s10434-021-10645.
    PubMed     Abstract available


  345. CHE BAKRI NA, Kwasnicki RM, Dhillon K, Khan N, et al
    ASO Visual Abstract: Objective Assessment of Postoperative Morbidity Following Breast Cancer Treatments with Wearable Activity Monitors: The "BRACELET" Study.
    Ann Surg Oncol. 2021 Sep 9. pii: 10.1245/s10434-021-10597.
    PubMed    


  346. STAHL KA, Wong W, Olecki EJ, McLaughlin C, et al
    ASO Visual Abstract: Benefits of Trimodality Therapy Compared with Systemic Therapy Alone in Male Patients with Stage IV Breast Cancer.
    Ann Surg Oncol. 2021 Sep 6. pii: 10.1245/s10434-021-10783.
    PubMed    


  347. ABI JAOUDE J, Zeidan YH
    ASO Author Reflections: Postmastectomy Radiation Therapy: Focus on Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10547.
    PubMed    


  348. KASSAMANI YW, Brunelle CL, Gillespie TC, Bernstein MC, et al
    ASO Visual Abstract: Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity-The Need for Universal Agreement.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10683.
    PubMed    


  349. STAHL KA, Wong W, Olecki EJ, McLaughlin C, et al
    Benefits of Trimodality Therapy Compared with Systemic Therapy Alone in Male Patients with Stage IV Breast Cancer.
    Ann Surg Oncol. 2021 Sep 3. pii: 10.1245/s10434-021-10729.
    PubMed     Abstract available


  350. JOHNSON BA, Lindgren BR, Blaes AH, Parsons HM, et al
    ASO Visual Abstract: The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care.
    Ann Surg Oncol. 2021 Sep 2. pii: 10.1245/s10434-021-10687.
    PubMed    


  351. GREEN RT, Weiser R, Golan O, Menes TS, et al
    In Search of the Lost Clip: Outcome of Women After Needle-Guided Lumpectomy of a Marking Clip.
    Ann Surg Oncol. 2021;28:4974-4980.
    PubMed     Abstract available


  352. KRAFT E, Limberg JN, Dodelzon K, Newman LA, et al
    Radial Scars and Complex Sclerosing Lesions of the Breast: Prevalence of Malignancy and Natural History Under Active Surveillance.
    Ann Surg Oncol. 2021;28:5149-5155.
    PubMed     Abstract available


  353. TSANGARIS E, Pusic AL, Kaur MN, Voineskos S, et al
    Development and Psychometric Validation of the BREAST-Q Animation Deformity Scale for Women Undergoing an Implant-Based Breast Reconstruction After Mastectomy.
    Ann Surg Oncol. 2021;28:5183-5193.
    PubMed     Abstract available


  354. CEN C, Chun J, Kaplowitz E, Axelrod D, et al
    Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.
    Ann Surg Oncol. 2021;28:5142-5148.
    PubMed     Abstract available


  355. MCCORMICK PJ, Assel M, Van Zee KJ, Vickers AJ, et al
    Intraoperative Ketorolac is Associated with Risk of Reoperation After Mastectomy: A Single-Center Examination.
    Ann Surg Oncol. 2021;28:5134-5140.
    PubMed     Abstract available


  356. FRIEDRICH AU, Reisenbichler ES, Heller DR, LeBlanc JM, et al
    Characteristics and Long-Term Risk of Breast Angiosarcoma.
    Ann Surg Oncol. 2021;28:5112-5118.
    PubMed     Abstract available


  357. BALCH CM
    The Surgical Legacy of Randolph Lee Clark, Jr, MD: First Director and Surgeon-in-Chief of University of Texas MD Anderson Cancer Center II. Surgical Practice and Leadership at University of Texas MD Anderson Cancer Center (1946-1978).
    Ann Surg Oncol. 2021;28:4794-4804.
    PubMed     Abstract available


  358. SCHREIBER KL, Zinboonyahgoon N, Flowers KM, Hruschak V, et al
    Prediction of Persistent Pain Severity and Impact 12 Months After Breast Surgery Using Comprehensive Preoperative Assessment of Biopsychosocial Pain Modulators.
    Ann Surg Oncol. 2021;28:5015-5038.
    PubMed     Abstract available


  359. SHAH C, Jia X, Hobbs BP, Tendulkar RD, et al
    Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis.
    Ann Surg Oncol. 2021;28:4985-4994.
    PubMed     Abstract available


  360. ASGEIRSSON KS, Dixon JM, Darrigues L, Sarfati B, et al
    Multicenter Evaluation of Hydrodissection-Assisted Mastectomy (HAM).
    Ann Surg Oncol. 2021;28:4780-4781.
    PubMed    


  361. SCHAVERIEN MV, Chang EI
    Discussion: "Development and Psychometric Validation of a Patient-Reported Outcome Measure for Arm Lymphedema: LYMPH-Q Upper Extremity Module".
    Ann Surg Oncol. 2021;28:4767-4768.
    PubMed    


  362. TUTTLE TM, Burke EE, Hui JYC
    Genetic Testing and De-escalation of Contralateral Prophylactic Mastectomy.
    Ann Surg Oncol. 2021;28:4764-4766.
    PubMed    


  363. MCCORMICK PJ, Simon BA
    ASO Author Reflections: We No Longer Give Ketorolac During Mastectomy. Should You?
    Ann Surg Oncol. 2021;28:5141.
    PubMed    


  364. FRIEDRICH AU, Lannin DR
    ASO Author Reflections: Breast Angiosarcoma-A Rare Disease with a Lot of Uncertainty.
    Ann Surg Oncol. 2021;28:5119-5120.
    PubMed    


  365. TADROS AB, Sevilimedu V, Plitas G
    Reply to: Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?
    Ann Surg Oncol. 2021;28:5440-5441.
    PubMed    


  366. CORSO G
    Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which Is Worst?
    Ann Surg Oncol. 2021;28:5438-5439.
    PubMed    


    August 2021
  367. CAO L, Sugumar K, Keller E, Li P, et al
    ASO Visual Abstract: Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor Positive Breast Cancer Patients-Pathologic and Surgical Outcomes.
    Ann Surg Oncol. 2021 Aug 30. pii: 10.1245/s10434-021-10600.
    PubMed    


  368. FAYANJU OM
    Black-White Differences in Treatment Receipt and Outcome for Triple-Negative Breast Cancer: The Competing Contributions of Access, Bias, and Biology.
    Ann Surg Oncol. 2021 Aug 26. pii: 10.1245/s10434-021-10697.
    PubMed    


  369. LIM DW, Hong NJL
    ASO Author Reflections: Identifying pCR After Neoadjuvant Chemotherapy: The Key to Treatment De-escalation in Breast Cancer.
    Ann Surg Oncol. 2021 Aug 25. pii: 10.1245/s10434-021-10699.
    PubMed    


  370. DILLON J, Thomas SM, Rosenberger LH, DiLalla G, et al
    ASO Visual Abstract: Mortality in Older Patients with Breast Cancer Undergoing Breast Surgery-How Low is "Low Risk"?
    Ann Surg Oncol. 2021 Aug 25. pii: 10.1245/s10434-021-10612.
    PubMed    


  371. OROZCO JIJ, Chang SC, Matsuba C, Ensenyat-Mendez M, et al
    ASO Visual Abstract: Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? : A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens.
    Ann Surg Oncol. 2021 Aug 25. pii: 10.1245/s10434-021-10589.
    PubMed    


  372. CHE BAKRI NA, Kwasnicki RM, Dhillon K, Khan N, et al
    ASO Author Reflections: Improving Management of Upper Limb Complications after Breast Cancer Treatments.
    Ann Surg Oncol. 2021 Aug 24. pii: 10.1245/s10434-021-10603.
    PubMed    


  373. YUAN Q, Hou J, Zhou R, Zheng L, et al
    ASO Visual Abstract: Stepwise Limited Axillary Lymph Node Dissection Based on Lymphatic Drainage from the Breast to Decrease Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
    Ann Surg Oncol. 2021 Aug 24. pii: 10.1245/s10434-021-10703.
    PubMed    


  374. WILKE LG, Nguyen TT, Yang Q, Hanlon BM, et al
    Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer: Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries.
    Ann Surg Oncol. 2021 Aug 24. pii: 10.1245/s10434-021-10639.
    PubMed     Abstract available


  375. SARIDAKIS A, Berger ER, Harigopal M, Park T, et al
    Apocrine Breast Cancer: Unique Features of a Predominantly Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2021 Aug 23. pii: 10.1245/s10434-021-10518.
    PubMed     Abstract available


  376. LIM DW, Greene BD, Hong NJL
    ASO Visual Abstract: Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Aug 18. pii: 10.1245/s10434-021-10625.
    PubMed    


  377. CHAGPAR AB, Berger E, Alperovich M, Zanieski G, et al
    ASO Visual Abstract: Assessing Interobserver Variability of Cosmetic Outcome Assessment in Breast Cancer Patients Undergoing Breast Conservation Surgery.
    Ann Surg Oncol. 2021 Aug 18. pii: 10.1245/s10434-021-10584.
    PubMed    


  378. KANTOR O, Mittendorf EA
    ASO Author Reflections: Racial and Socioeconomic Disparities in Breast Cancer Mortality Persist Beyond Tumor Biology.
    Ann Surg Oncol. 2021 Aug 17. pii: 10.1245/s10434-021-10655.
    PubMed    


  379. FINE RE, Gilmore RC, Dietz JR, Boolbol SK, et al
    ASO Visual Abstract: Cryoablation Without Excision for Low-Risk, Early-Stage Breast Cancer-3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
    Ann Surg Oncol. 2021 Aug 16. pii: 10.1245/s10434-021-10618.
    PubMed    


  380. KULKARNI SA, Kulkarni K, Schacht D, Bhole S, et al
    ASO Visual Abstract: High-Resolution Full 3D Specimen Imaging for Lumpectomy Margin Assessment in Breast Cancer.
    Ann Surg Oncol. 2021 Aug 16. pii: 10.1245/s10434-021-10610.
    PubMed    


  381. WILKE LG, Nguyen TT, Yang Q, Hanlon BM, et al
    ASO Visual Abstract: Analysis of the Impact of the COVID-19 Pandemic on the Multidisciplinary Management of Breast Cancer-Review from the American Society of Breast Surgeons COVID-19 and Mastery Registries.
    Ann Surg Oncol. 2021 Aug 16. pii: 10.1245/s10434-021-10619.
    PubMed    


  382. FINE RE, Gilmore RC, Dietz JR, Boolbol SK, et al
    Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
    Ann Surg Oncol. 2021 Aug 15. pii: 10.1245/s10434-021-10501.
    PubMed     Abstract available


  383. HUYNH V, Colborn K, Smith S, Bonnell LN, et al
    ASO Visual Abstract: Early Trajectories of Patient-Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy.
    Ann Surg Oncol. 2021 Aug 15. pii: 10.1245/s10434-021-10590.
    PubMed    


  384. TONNESON JE, Hoskin TL, Durgan DM, Corbin KS, et al
    ASO Visual Abstract: Decreasing the Use of Sentinel Lymph Node Surgery in Women Over 70 Years Old with Hormone Receptor Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy.
    Ann Surg Oncol. 2021 Aug 15. pii: 10.1245/s10434-021-10476.
    PubMed    


  385. CORIDDI M, Kim L, McGrath L, Encarnacion E, et al
    ASO Visual Abstract: Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Aug 13. pii: 10.1245/s10434-021-10538.
    PubMed    


  386. ADESOYE T, Lucci A
    ASO Visual Abstract: Current Surgical Management of Inflammatory Breast Cancer.
    Ann Surg Oncol. 2021 Aug 13. pii: 10.1245/s10434-021-10623.
    PubMed    


  387. THOMPSON J, Wright GP
    ASO Author Reflections: Overtreatment of Older Females with Favorable-Prognosis Breast Cancer.
    Ann Surg Oncol. 2021 Aug 12. pii: 10.1245/s10434-021-10613.
    PubMed    


  388. NASH AL, Thomas SM, Plichta JK, Fayanju OM, et al
    ASO Visual Abstract: Contralateral Axillary Nodal Metastases-Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?
    Ann Surg Oncol. 2021 Aug 12. pii: 10.1245/s10434-021-10605.
    PubMed    


  389. THOMPSON J, Le J, Hop A, Melnik M, et al
    ASO Visual Abstract: Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 with Hormone Positive Breast Cancer.
    Ann Surg Oncol. 2021 Aug 11. pii: 10.1245/s10434-021-10598.
    PubMed    


  390. BOUGHEY JC, Nguyen TT, Dietz JR, Wilke LG, et al
    ASO Authors Reflection: Lessons Learned from the COVID-19 Pandemic-Should We Change Surgical Management of Patients with Breast Cancer?
    Ann Surg Oncol. 2021 Aug 11. pii: 10.1245/s10434-021-10630.
    PubMed    


  391. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
    ASO Visual Abstract: Institutions Treating Breast Cancer Patients of a Low Socioeconomic Status Achieve Multidisciplinary Quality Standards at Lower Rates.
    Ann Surg Oncol. 2021 Aug 11. pii: 10.1245/s10434-021-10577.
    PubMed    


  392. NAGRA NS, Tsangaris E, Means J, Hassett MJ, et al
    ASO Visual Abstract: Time-Driven Activity-Based Costing (TDABC) in Breast Cancer Care Delivery.
    Ann Surg Oncol. 2021 Aug 10. pii: 10.1245/s10434-021-10537.
    PubMed    


  393. COCCO D, ElSherif A, Wright MD, Dempster MS, et al
    ASO Visual Abstract: Invasive Lobular Breast Cancer-Data to Support Surgical Decision-Making.
    Ann Surg Oncol. 2021 Aug 10. pii: 10.1245/s10434-021-10599.
    PubMed    


  394. LIM DW, Greene BD, Look Hong NJ
    Relationship Between Breast and Axillary Pathologic Complete Response in Women Receiving Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Aug 10. pii: 10.1245/s10434-021-10519.
    PubMed     Abstract available


  395. NAGRA NS, Tsangaris E, Means J, Hassett MJ, et al
    Time-Driven Activity-Based Costing in Breast Cancer Care Delivery.
    Ann Surg Oncol. 2021 Aug 10. pii: 10.1245/s10434-021-10465.
    PubMed     Abstract available


  396. JOHNSON BA, Hui JYC
    ASO Author Reflections: The Patient Perspective of Telemedicine in Breast Cancer Care.
    Ann Surg Oncol. 2021 Aug 9. pii: 10.1245/s10434-021-10592.
    PubMed    


  397. COCCO D, Valente SA
    ASO Author Reflection: Updating our Knowledge on Invasive Lobular Breast Cancer.
    Ann Surg Oncol. 2021 Aug 9. pii: 10.1245/s10434-021-10615.
    PubMed    


  398. KANTOR O, Wang ML, Bertrand K, Pierce L, et al
    ASO Visual Abstract: Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System.
    Ann Surg Oncol. 2021 Aug 8. pii: 10.1245/s10434-021-10575.
    PubMed    


  399. HERREMANS KM, Cribbin MP, Riner AN, Neal DW, et al
    Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Ann Surg Oncol. 2021 Aug 7. pii: 10.1245/s10434-021-10551.
    PubMed     Abstract available


  400. KULKARNI SA, Han X
    ASO Author Reflections: Volumetric Specimen Imaging for Margin Assessment in Breast Cancer.
    Ann Surg Oncol. 2021 Aug 7. pii: 10.1245/s10434-021-10622.
    PubMed    


  401. NAFFOUJE SA, Sabesan A, Hoover SJ, Lee MC, et al
    ASO Visual Abstract: Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer Database.
    Ann Surg Oncol. 2021 Aug 6. pii: 10.1245/s10434-021-10481.
    PubMed    


  402. ADESOYE T, Lucci A
    Current Surgical Management of Inflammatory Breast Cancer.
    Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10522.
    PubMed     Abstract available


  403. CAO L, Sugumar K, Keller E, Li P, et al
    Neoadjuvant Endocrine Therapy as an Alternative to Neoadjuvant Chemotherapy Among Hormone Receptor-Positive Breast Cancer Patients: Pathologic and Surgical Outcomes.
    Ann Surg Oncol. 2021 Aug 3. pii: 10.1245/s10434-021-10459.
    PubMed     Abstract available


  404. PILTIN MA, Hoskin TL, Day CN, Shumway DA, et al
    Use of the Twelve-Gene Recurrence Score for Ductal Carcinoma in Situ and Its Influence on Receipt of Adjuvant Radiation and Hormonal Therapy.
    Ann Surg Oncol. 2021;28:4294-4303.
    PubMed     Abstract available


  405. PAWLOSKI KR, Wen HY, Tadros AB, Abbate K, et al
    Concordance Between 21-Gene Recurrence Scores in Multifocal or Multicentric Breast Carcinomas Differs by Age and Histologic Subtype.
    Ann Surg Oncol. 2021;28:4256-4262.
    PubMed     Abstract available


  406. CRIPPA S, Giannone F, Schiavo Lena M, Belfiori G, et al
    R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:4602-4612.
    PubMed     Abstract available


  407. HE Q, Chen J, Zhou K, Jin C, et al
    Effect of Additional Trastuzumab in Neoadjuvant and Adjuvant Treatment for Patients with Resectable HER2-Positive Gastric Cancer.
    Ann Surg Oncol. 2021;28:4413-4422.
    PubMed     Abstract available


  408. CRIPPA S, Giannone F, Lena MS, Falconi M, et al
    ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:4613-4614.
    PubMed    


  409. WU ZY, Han J, Eom JS, Ahn SH, et al
    ASO Author Reflections: Do Shorter Tumor-to-Nipple Distances Compromise the Local Oncologic Safety of Nipple-Sparing Mastectomy?
    Ann Surg Oncol. 2021;28:4292-4293.
    PubMed    


  410. PAWLOSKI KR, Tadros AB, El-Tamer M
    ASO Author Reflections: Age Is an Important Determinant of Concordance Between 21-Gene Recurrence Scores in Multiple Ipsilateral Breast Carcinomas.
    Ann Surg Oncol. 2021;28:4263-4264.
    PubMed    


    July 2021
  411. PARK KU, Birken S, Garvin J, Carson W 3rd, et al
    ASO Visual Abstract: Practical Guide to Implementation Science for Surgical Oncologists: Case Study of Breast Cancer Short Stay Program.
    Ann Surg Oncol. 2021 Jul 31. pii: 10.1245/s10434-021-10536.
    PubMed    


  412. DESNYDER SM, Yi M, Boccardo F, Feldman S, et al
    American Society of Breast Surgeons' Practice Patterns for Patients at Risk and Affected by Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Jul 31. pii: 10.1245/s10434-021-10494.
    PubMed     Abstract available


  413. KULKARNI SA, Kulkarni K, Schacht D, Bhole S, et al
    High-Resolution Full-3D Specimen Imaging for Lumpectomy Margin Assessment in Breast Cancer.
    Ann Surg Oncol. 2021 Jul 31. pii: 10.1245/s10434-021-10499.
    PubMed     Abstract available


  414. THOMPSON J, Le J, Hop A, Melnik M, et al
    Impact of Choosing Wisely Recommendations on Sentinel Lymph Node Biopsy and Postoperative Radiation Rates in Women Over Age 70 Years with Hormone-Positive Breast Cancer.
    Ann Surg Oncol. 2021 Jul 31. pii: 10.1245/s10434-021-10460.
    PubMed     Abstract available


  415. YUAN Q, Hou J, Zhou R, Zheng L, et al
    Stepwise Limited Axillary Lymph Node Dissection Based on Lymphatic Drainage from the Breast to Decrease Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.
    Ann Surg Oncol. 2021 Jul 30. pii: 10.1245/s10434-021-10526.
    PubMed     Abstract available


  416. KANTOR O, Wang ML, Bertrand K, Pierce L, et al
    Racial and Socioeconomic Disparities in Breast Cancer Outcomes within the AJCC Pathologic Prognostic Staging System.
    Ann Surg Oncol. 2021 Jul 30. pii: 10.1245/s10434-021-10527.
    PubMed     Abstract available


  417. KAYALI M, Abi Jaoude J, Mohammed M, Khabsa J, et al
    Post-mastectomy Radiation Therapy in Triple-Negative Breast Cancer Patients: Analysis of the BEATRICE Trial.
    Ann Surg Oncol. 2021 Jul 29. pii: 10.1245/s10434-021-10511.
    PubMed     Abstract available


  418. COCCO D, ElSherif A, Wright MD, Dempster MS, et al
    Invasive Lobular Breast Cancer: Data to Support Surgical Decision Making.
    Ann Surg Oncol. 2021 Jul 29. pii: 10.1245/s10434-021-10455.
    PubMed     Abstract available


  419. DILLON J, Thomas SM, Rosenberger LH, DiLalla G, et al
    Mortality in Older Patients with Breast Cancer Undergoing Breast Surgery: How Low is "Low Risk"?
    Ann Surg Oncol. 2021 Jul 26. pii: 10.1245/s10434-021-10502.
    PubMed     Abstract available


  420. CHE BAKRI NA, Kwasnicki RM, Dhillon K, Khan N, et al
    Objective Assessment of Postoperative Morbidity After Breast Cancer Treatments with Wearable Activity Monitors: The "BRACELET" Study.
    Ann Surg Oncol. 2021 Jul 26. pii: 10.1245/s10434-021-10458.
    PubMed     Abstract available


  421. PARK KU, Birken S, Garvin J, Carson W 3rd, et al
    Practical Guide to Implementation Science for Surgical Oncologists: Case Study of Breast Cancer Short Stay Program.
    Ann Surg Oncol. 2021 Jul 23. pii: 10.1245/s10434-021-10479.
    PubMed     Abstract available


  422. ADESOYE T, Babayemi O, Postlewait LM, DeSnyder SM, et al
    Inflammatory Breast Cancer at the Extremes of Age.
    Ann Surg Oncol. 2021 Jul 22. pii: 10.1245/s10434-021-10453.
    PubMed     Abstract available


  423. SAUDER CAM, Li Q, Bold RJ, Ruddy KJ, et al
    ASO Visual Abstract: Secondary Breast Cancer Sociodemographic Characteristics and Survival by Age Group.
    Ann Surg Oncol. 2021 Jul 22. pii: 10.1245/s10434-021-10389.
    PubMed    


  424. NASH AL, Thomas SM, Plichta JK, Fayanju OM, et al
    Contralateral Axillary Nodal Metastases: Stage IV Disease or a Manifestation of Progressive Locally Advanced Breast Cancer?
    Ann Surg Oncol. 2021 Jul 21. pii: 10.1245/s10434-021-10461.
    PubMed     Abstract available


  425. SAUDER CAM, Keegan THM
    ASO Author Reflections: Decreased Survival from Secondary Breast Cancer in Women of All Ages.
    Ann Surg Oncol. 2021 Jul 19. pii: 10.1245/s10434-021-10399.
    PubMed    


  426. JOHNSON BA, Lindgren BR, Blaes AH, Parsons HM, et al
    The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care.
    Ann Surg Oncol. 2021 Jul 17. pii: 10.1245/s10434-021-10448.
    PubMed     Abstract available


  427. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
    ASO Visual Abstract: Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Ann Surg Oncol. 2021 Jul 17. pii: 10.1245/s10434-021-10483.
    PubMed    


  428. FURLAN C, Matheus CN, Jales RM, Derchain SFM, et al
    ASO Visual Abstract: Longitudinal, Long-Term Comparison of Single-Versus Multi-Point Upper Limb Circumference Periodical Measurements as a Tool to Predict Persistent Lymphedema in Women Treated Surgically for Breast Cancer : An Optimized Strategy to E
    Ann Surg Oncol. 2021 Jul 17. pii: 10.1245/s10434-021-10338.
    PubMed    


  429. HOFFMAN DI, Santos PMG, Goldbach M, Keele LJ, et al
    ASO Visual Abstract: Immediate Breast Reconstruction for Inflammatory Breast Cancer-Trends in Use and Clinical Outcomes, 2004-2016.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10475.
    PubMed    


  430. WILLIAMS AD, Ciocca R, Sabol JL, Carp NZ, et al
    Institutions Treating Breast Cancer Patients of a Low Socioeconomic Status Achieve Multidisciplinary Quality Standards at Lower Rates.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10451.
    PubMed     Abstract available


  431. HOFFMAN DI, Santos PMG, Goldbach M, Keele LJ, et al
    Immediate Breast Reconstruction for Inflammatory Breast Cancer: Trends in Use and Clinical Outcomes 2004-2016.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10404.
    PubMed     Abstract available


  432. HOFFMAN DI, Santos PMG, Tchou JC
    ASO Author Reflections: Immediate Breast Reconstruction in Patients with Inflammatory Breast Cancer-A Rising Trend.
    Ann Surg Oncol. 2021 Jul 16. pii: 10.1245/s10434-021-10486.
    PubMed    


  433. CHAGPAR AB, Berger E, Alperovich M, Zanieski G, et al
    Assessing Interobserver Variability of Cosmetic Outcome Assessment in Breast Cancer Patients Undergoing Breast-Conservation Surgery.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10442.
    PubMed     Abstract available


  434. GOLDBACH MM, Burkbauer L, Bharani T, Williams AD, et al
    Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016).
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10403.
    PubMed    


  435. CORIDDI M, Kim L, McGrath L, Encarnacion E, et al
    Accuracy, Sensitivity, and Specificity of the LLIS and ULL27 in Detecting Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10469.
    PubMed     Abstract available


  436. HUYNH V, Colborn K, Smith S, Bonnell LN, et al
    Early Trajectories of Patient Reported Outcomes in Breast Cancer Patients Undergoing Lumpectomy Versus Mastectomy.
    Ann Surg Oncol. 2021 Jul 15. pii: 10.1245/s10434-021-10450.
    PubMed     Abstract available


  437. WEISER R, Polychronopoulou E, Haque W, Hatch SS, et al
    ASO Visual Abstract: Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases-An NCDB Analysis.
    Ann Surg Oncol. 2021 Jul 14. pii: 10.1245/s10434-021-10419.
    PubMed    


  438. NAFFOUJE SA, Sabesan A, Hoover SJ, Lee MC, et al
    Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB.
    Ann Surg Oncol. 2021 Jul 14. pii: 10.1245/s10434-021-10411.
    PubMed     Abstract available


  439. TONNESON JE, Hoskin TL, Durgan DM, Corbin KS, et al
    Decreasing the Use of Sentinel Lymph Node Surgery in Women Older than 70 Years with Hormone Receptor-Positive Breast Cancer and the Impact on Adjuvant Radiation and Hormonal Therapy.
    Ann Surg Oncol. 2021 Jul 13. pii: 10.1245/s10434-021-10407.
    PubMed     Abstract available


  440. WEISER R, Klimberg VS
    ASO Author Reflections: Breast Cancer: What is in a Positive Node?
    Ann Surg Oncol. 2021 Jul 13. pii: 10.1245/s10434-021-10436.
    PubMed    


  441. TASKINDOUST M, Thomas SM, Sammons S, Fayanju OM, et al
    ASO Visual Abstract: Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients.
    Ann Surg Oncol. 2021 Jul 13. pii: 10.1245/s10434-021-10296.
    PubMed    


  442. LIZARRAGA IM, Schroeder MC, Jatoi I, Sugg SL, et al
    Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Ann Surg Oncol. 2021 Jul 12. pii: 10.1245/s10434-021-10426.
    PubMed     Abstract available


  443. WEISER R, Polychronopoulou E, Haque W, Hatch SS, et al
    Prognosis and Chemotherapy Use in Breast Cancer Patients with Multiple Lymphatic Micrometastases: An NCDB Analysis.
    Ann Surg Oncol. 2021 Jul 11. pii: 10.1245/s10434-021-10374.
    PubMed     Abstract available


  444. ELMORE LC, Kuerer HM, Barcenas CH, Smith BD, et al
    Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2021 Jul 10. pii: 10.1245/s10434-021-10444.
    PubMed     Abstract available


  445. BLOOM JA, Sekigami Y, Young R, Macera L, et al
    Discordance in Oncotype DX Breast Recurrence Score((R)) Results for Bilateral Breast Cancer.
    Ann Surg Oncol. 2021 Jul 9. pii: 10.1245/s10434-021-10387.
    PubMed     Abstract available


  446. OROZCO JIJ, Chang SC, Matsuba C, Ensenyat-Mendez M, et al
    Is the 21-Gene Recurrence Score on Core Needle Biopsy Equivalent to Surgical Specimen in Early-Stage Breast Cancer? A Comparison of Gene Expression Between Paired Core Needle Biopsy and Surgical Specimens.
    Ann Surg Oncol. 2021 Jul 9. pii: 10.1245/s10434-021-10457.
    PubMed     Abstract available


  447. BLOOM JA, Sekigami Y, Young R, Macera L, et al
    ASO Visual Abstract: Discordance in Oncotype DX Breast Recurrence Score(R) Results for Bilateral Breast Cancer.
    Ann Surg Oncol. 2021 Jul 8. pii: 10.1245/s10434-021-10429.
    PubMed    


  448. SORAN A, Sezgin E, Ozbas S, Dogan L, et al
    Reply: The Effect of Primary Surgery in Patients with Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-center, Registry Study.
    Ann Surg Oncol. 2021 Jul 7. pii: 10.1245/s10434-021-10396.
    PubMed    


  449. JIWA N, Gandhewar R, Chauhan H, Ashrafian H, et al
    Diagnostic Accuracy of Nipple Aspirate Fluid Cytology in Asymptomatic Patients: A Meta-analysis and Systematic Review of the Literature.
    Ann Surg Oncol. 2021;28:3751-3760.
    PubMed     Abstract available


    June 2021
  450. SAUDER CAM, Li Q, Bold RJ, Ruddy KJ, et al
    Secondary Breast Cancer Sociodemographic Characteristics and Survival by Age Group.
    Ann Surg Oncol. 2021 Jun 29. pii: 10.1245/s10434-021-10340.
    PubMed     Abstract available


  451. GOLDBACH MM, Burkbauer L, Bharani T, Williams AD, et al
    ASO Visual Abstract: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016).
    Ann Surg Oncol. 2021 Jun 28. pii: 10.1245/s10434-021-10353.
    PubMed    


  452. FURLAN C, Matheus CN, Jales RM, Derchain SFM, et al
    ASO Author Reflections: A Roadmap to Early Detection of Patients at Increased Risk of Developing Persistent Lymphedema After Breast Cancer Surgery Has Been Outlined: What to Offer Them Remains Elusive.
    Ann Surg Oncol. 2021 Jun 27. pii: 10.1245/s10434-021-10360.
    PubMed    


  453. KOUWENBERG CAE, Kranenburg LW, Busschbach JJ, Mureau MAM, et al
    Why Breast-Conserving Therapy Should be Considered Treatment of Choice in Early-Stage Breast Cancer Patients.
    Ann Surg Oncol. 2021 Jun 26. pii: 10.1245/s10434-021-10203.
    PubMed    


  454. MYERS SP, Ahrendt GM, Lee JS, Steiman JG, et al
    Association of Tumor Molecular Subtype and Stage with Breast and Axillary Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Jun 17. pii: 10.1245/s10434-021-10195.
    PubMed     Abstract available


  455. SROUR MK, Tseng J, Chung A, Giuliano AE, et al
    Contemporary Cancer Program Practice Profile Report (CP3R) Compliance Rates for Breast Cancer: A National Cancer Database Analysis.
    Ann Surg Oncol. 2021 Jun 16. pii: 10.1245/s10434-021-10028.
    PubMed     Abstract available


  456. GOLDBACH MM, Burkbauer L, Bharani T, Williams AD, et al
    Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer-An NCDB Analysis (2004-2016).
    Ann Surg Oncol. 2021 Jun 14. pii: 10.1245/s10434-021-10287.
    PubMed     Abstract available


  457. POSTLEWAIT LM, Teshome M, Adesoye T, DeSnyder SM, et al
    Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2021 Jun 14. pii: 10.1245/s10434-021-10148.
    PubMed     Abstract available


  458. FURLAN C, Matheus CN, Jales RM, Derchain SFM, et al
    Longitudinal, Long-Term Comparison of Single- versus Multipoint Upper Limb Circumference Periodical Measurements as a Tool to Predict Persistent Lymphedema in Women Treated Surgically for Breast Cancer: An Optimized Strategy to Early Diagnose Lymphede
    Ann Surg Oncol. 2021 Jun 14. pii: 10.1245/s10434-021-10290.
    PubMed     Abstract available


  459. BUCCI LK, Brunelle CL, Bernstein MC, Shui AM, et al
    Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.
    Ann Surg Oncol. 2021 Jun 11. pii: 10.1245/s10434-021-10173.
    PubMed     Abstract available


  460. CHEN G, Jia M, Zeng Q, Zhang H, et al
    Development and Validation of Web-Based Nomograms for Predicting Cause-Specific Mortality in Surgically Resected Nonmetastatic Invasive Breast Cancer: A Population-Based Study.
    Ann Surg Oncol. 2021 Jun 10. pii: 10.1245/s10434-021-10129.
    PubMed     Abstract available


  461. PRATT D, Burneikis T, Tu C, Grobmyer S, et al
    Time to Completion of Breast Cancer Treatment and Survival.
    Ann Surg Oncol. 2021 Jun 8. pii: 10.1245/s10434-021-10116.
    PubMed     Abstract available


  462. CLARKE CN, Cortina CS, Fayanju OM, Dossett LA, et al
    Breast Cancer Risk and Screening in Transgender Persons: A Call for Inclusive Care.
    Ann Surg Oncol. 2021 Jun 7. pii: 10.1245/s10434-021-10217.
    PubMed     Abstract available


  463. POSTLEWAIT LM, Lucci A
    ASO Author Reflections: Metastasis of Inflammatory Breast Cancer to the Contralateral Axilla: A Finding Meriting Further Study.
    Ann Surg Oncol. 2021 Jun 2. pii: 10.1245/s10434-021-10208.
    PubMed    


  464. CHEN G, Jia M, Zeng Q, Zhang H, et al
    ASO Visual Abstract: Development and Validation of Web-Based Nomograms for Predicting Cause-Specific Mortality in Surgically Resected Nonmetastatic Invasive Breast Cancer: A Population-Based Study.
    Ann Surg Oncol. 2021 Jun 2. pii: 10.1245/s10434-021-10154.
    PubMed    


  465. MILLER ME, Patil N, Li P, Freyvogel M, et al
    Hospital System Adoption of Magnetic Seeds for Wireless Breast and Lymph Node Localization.
    Ann Surg Oncol. 2021;28:3223-3229.
    PubMed     Abstract available


  466. DA COSTA VIEIRA RA, de Oliveira-Junior I, Branquinho LI, Haikel RL, et al
    Modified External Oblique Myocutaneous Flap for Repair of Postmastectomy Defects in Locally Advanced Breast Tumors: A Cohort Series Associated with a Systematic Review of Literature.
    Ann Surg Oncol. 2021;28:3356-3364.
    PubMed     Abstract available


  467. MILLER ME, Dietz J
    ASO Author Reflections: Magnetic Seed Localization and Tracers Add Value to Multidisciplinary Breast Programs.
    Ann Surg Oncol. 2021;28:3230-3231.
    PubMed    


  468. LEON P, Panaro F
    ASO Author Reflections: Exploring the Oncologic Impact of Pancreatic Fistula after Distal Pancreatectomy for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:3184-3185.
    PubMed    


    May 2021
  469. POSTLEWAIT LM, Teshome M, Adesoye T, DeSnyder SM, et al
    ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer.
    Ann Surg Oncol. 2021 May 29. pii: 10.1245/s10434-021-10200.
    PubMed    


  470. TASKINDOUST M, Thomas SM, Sammons SL, Fayanju OM, et al
    Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients.
    Ann Surg Oncol. 2021 May 28. pii: 10.1245/s10434-021-10227.
    PubMed     Abstract available


  471. PRATT D, Grobmyer SR
    ASO Author Reflections: Time to Treatment: A New Quality Metric in Breast Cancer Care?
    Ann Surg Oncol. 2021 May 28. pii: 10.1245/s10434-021-10169.
    PubMed    


  472. PALSHOF FK, Lanng C, Kroman N, Benian C, et al
    Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in Neoadjuvant Setting.
    Ann Surg Oncol. 2021 May 27. pii: 10.1245/s10434-021-10117.
    PubMed     Abstract available


  473. BUCCI LK, Taghian AG
    ASO Author Reflections: The Promising Potential of Early Intervention for Subclinical Lymphedema in Women Who Underwent Nodal Surgery for Breast Cancer.
    Ann Surg Oncol. 2021 May 25. pii: 10.1245/s10434-021-10176.
    PubMed    


  474. SATTAVAN S, Agarwal G
    Comments on "Breast-Conserving Therapy is Associated with Improved Survival compared with Mastectomy for Early-Stage Breast Cancer: A Propensity Score Matched Comparison Using the National Cancer Database".
    Ann Surg Oncol. 2021 May 24. pii: 10.1245/s10434-021-10149.
    PubMed    


  475. BUCCI LK, Brunelle CL, Bernstein MC, Shui AM, et al
    ASO Visual Abstract: Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.
    Ann Surg Oncol. 2021 May 23. pii: 10.1245/s10434-021-10196.
    PubMed    


  476. SHOWALTER SL, Meneveau MO, Keim-Malpass J, Camacho TF, et al
    Correction to: Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 May 22. pii: 10.1245/s10434-021-10216.
    PubMed    


  477. PALSHOF FK, Kroman N, Tvedskov TF
    ASO Author Reflections: The Role of Imaging Modalities in Omitting Surgery in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2021 May 22. pii: 10.1245/s10434-021-10178.
    PubMed    


  478. PALSHOF FK, Lanng C, Kroman N, Benian C, et al
    ASO Visual Abstract: Prediction of Pathologic Complete Response in Breast Cancer Patients Comparing Magnetic Resonance Imaging with Ultrasound in the Neoadjuvant Setting.
    Ann Surg Oncol. 2021 May 21. pii: 10.1245/s10434-021-10158.
    PubMed    


  479. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
    ASO Visual Abstract: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
    Ann Surg Oncol. 2021 May 19. pii: 10.1245/s10434-021-10098.
    PubMed    


  480. CAO L, Hue JJ, Freyvogel M, Li P, et al
    Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer.
    Ann Surg Oncol. 2021 May 16. pii: 10.1245/s10434-021-09994.
    PubMed    


  481. WEISS A, Campbell J, Ballman KV, Sikov WM, et al
    ASO Visual Abstract: Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance).
    Ann Surg Oncol. 2021 May 15. pii: 10.1245/s10434-021-10005.
    PubMed    


  482. SHOWALTER SL, Meneveau MO, Keim-Malpass J, Camacho TF, et al
    ASO Visual Abstract: Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women With Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 May 14. pii: 10.1245/s10434-021-10096.
    PubMed    


  483. GOMMERS JJJ, Duijm LEM, Bult P, Strobbe LJA, et al
    ASO Visual Abstract: The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study.
    Ann Surg Oncol. 2021 May 13. pii: 10.1245/s10434-021-10001.
    PubMed    


  484. SHOWALTER SL, Meneveau MO, Keim-Malpass J, Camacho TF, et al
    Effects of Adjuvant Endocrine Therapy Adherence and Radiation on Recurrence and Survival Among Older Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 May 12. pii: 10.1245/s10434-021-10064.
    PubMed     Abstract available


  485. VAN DER NOORDAA MEM, Ioan I, Rutgers EJ, van Werkhoven E, et al
    Breast-Conserving Therapy in Patients with cT3 Breast Cancer with Good Response to Neoadjuvant Systemic Therapy Results in Excellent Local Control: A Comprehensive Cancer Center Experience.
    Ann Surg Oncol. 2021 May 12. pii: 10.1245/s10434-021-09865.
    PubMed     Abstract available


  486. LAI HW, Chen ST, Liao CY, Mok CW, et al
    Oncologic Outcome of Endoscopic Assisted Breast Surgery Compared with Conventional Approach in Breast Cancer: An Analysis of 3426 Primary Operable Breast Cancer Patients from Single Institute with and Without Propensity Score Matching.
    Ann Surg Oncol. 2021 May 11. pii: 10.1245/s10434-021-09950.
    PubMed     Abstract available


  487. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
    ASO Author Reflections: High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
    Ann Surg Oncol. 2021 May 8. pii: 10.1245/s10434-021-10135.
    PubMed    


  488. SATYANANDA V, Oshi M, Endo I, Takabe K, et al
    High BRCA2 Gene Expression is Associated with Aggressive and Highly Proliferative Breast Cancer.
    Ann Surg Oncol. 2021 May 8. pii: 10.1245/s10434-021-10063.
    PubMed     Abstract available


  489. LAI HW, Chen ST, Liao CY, Mok CW, et al
    ASO Visual Abstract: Oncologic Outcome of Endoscopic-Assisted Breast Surgery Compared with Conventional Approach in Breast Cancer: An Analysis of 3426 Primary Operable Breast Cancer Patients from a Single Institute With and Without Propensity Score Ma
    Ann Surg Oncol. 2021 May 6. pii: 10.1245/s10434-021-09992.
    PubMed    


  490. KANTOR O, Laws A, Pastorello RG, King C, et al
    Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2021 May 6. pii: 10.1245/s10434-021-09951.
    PubMed     Abstract available


  491. MCKEVITT E, Cheifetz R, DeVries K, Laws A, et al
    ASO Visual Abstract: Sentinel Node Biopsy Should Not Be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
    Ann Surg Oncol. 2021 May 5. pii: 10.1245/s10434-021-09918.
    PubMed    


  492. LIM DW, Metcalfe KA
    ASO Author Reflections: Psychosocial Outcomes After Breast Cancer Treatment.
    Ann Surg Oncol. 2021 May 5. pii: 10.1245/s10434-021-10017.
    PubMed    


  493. LAI HW, Chen ST, Mok CW, Chang YT, et al
    Single-Port Three-Dimensional (3D) Videoscope-Assisted Endoscopic Nipple-Sparing Mastectomy in the Management of Breast Cancer: Technique, Clinical Outcomes, Medical Cost, Learning Curve, and Patient-Reported Aesthetic Results from 80 Preliminary Proc
    Ann Surg Oncol. 2021 May 1. pii: 10.1245/s10434-021-09964.
    PubMed     Abstract available


  494. BAKER JL, Dizon DS, Wenziger CM, Streja E, et al
    ASO Visual Abstract: "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.
    Ann Surg Oncol. 2021;28:2507.
    PubMed     Abstract available


  495. VANE MLG, Hunter-Squires J, Kim S, Smidt ML, et al
    Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy.
    Ann Surg Oncol. 2021;28:2522-2528.
    PubMed     Abstract available


  496. JOHNSON JE, Ollila DW, Boughey JC
    Surgical Options in Management of the Breast and Axilla: Independent Choices?
    Ann Surg Oncol. 2021;28:2421-2424.
    PubMed    


  497. GILMORE RC, Wang P, Kaczmarski K, Hutfless S, et al
    Underutilization of Needle Biopsy Before Breast Surgery: A Measure of Low-Value Care.
    Ann Surg Oncol. 2021;28:2485-2492.
    PubMed     Abstract available


  498. BAKER JL, Attai DJ
    ASO Author Reflections: Patients Who Go Flat After Mastectomy Deserve an Aesthetic Flat Closure.
    Ann Surg Oncol. 2021;28:2506.
    PubMed    


  499. BAKER JL, Dizon DS, Wenziger CM, Streja E, et al
    "Going Flat" After Mastectomy: Patient-Reported Outcomes by Online Survey.
    Ann Surg Oncol. 2021;28:2493-2505.
    PubMed     Abstract available


  500. DE ROOIJ L, van Kuijk SMJ, Granzier RWY, Hintzen KFH, et al
    Reducing Seroma Formation and Its Sequelae After Mastectomy by Closure of the Dead Space: A Multi-center, Double-Blind Randomized Controlled Trial (SAM-Trial).
    Ann Surg Oncol. 2021;28:2599-2608.
    PubMed     Abstract available


  501. ANGARITA S, DiNome M
    ASO Author Reflections: Moving the Ball Forward Toward De-Escalation of Axillary Surgery for Patients with Clinically Node-Positive Disease.
    Ann Surg Oncol. 2021;28:2619-2620.
    PubMed    


  502. NAKHLIS F, Baker GM, Pilewskie M, Gelman R, et al
    The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
    Ann Surg Oncol. 2021;28:2573-2578.
    PubMed     Abstract available


  503. SON JD, Piper M, Hewitt K, Alvarado M, et al
    Oncological Outcomes of Total Skin-Sparing Mastectomy for Invasive Lobular Carcinoma of the Breast: A 20-Year Institutional Experience.
    Ann Surg Oncol. 2021;28:2555-2560.
    PubMed     Abstract available


    April 2021
  504. CAO L, Hue JJ, Shenk R, Miller ME, et al
    Addressing Gender Disparity in Breast Cancer Care.
    Ann Surg Oncol. 2021 Apr 28. pii: 10.1245/s10434-021-09969.
    PubMed    


  505. LAI HW
    ASO Author Reflections: Single-Port Three-Dimensional (3D) Videoscope-Assisted Endoscopic Nipple-Sparing Mastectomy in Management of Breast Cancer.
    Ann Surg Oncol. 2021 Apr 28. pii: 10.1245/s10434-021-10010.
    PubMed    


  506. YUAN Q, Hou J, Zhou R, Liao Y, et al
    Development and Validation of an Intraoperative Nomogram to Predict Breast Cancer-Related Lymphedema Based on the Arm Lymphatics Distribution.
    Ann Surg Oncol. 2021 Apr 23. pii: 10.1245/s10434-021-09982.
    PubMed     Abstract available


  507. YUAN Q, Wu G
    ASO Author Reflections: Clinical Prediction Nomogram for Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2021 Apr 23. pii: 10.1245/s10434-021-10013.
    PubMed    


  508. YUAN Q, Hou J, Zhou R, Liao Y, et al
    ASO Visual Abstract: Development and Validation of an Intraoperative Nomogram to Predict Breast Cancer-Related Lymphedema Based on the Arm Lymphatics Distribution.
    Ann Surg Oncol. 2021 Apr 21. pii: 10.1245/s10434-021-10053.
    PubMed    


  509. KUIJER A, Dominici LS, Rosenberg SM, Hu J, et al
    Arm Morbidity After Local Therapy for Young Breast Cancer Patients.
    Ann Surg Oncol. 2021 Apr 21. pii: 10.1245/s10434-021-09947.
    PubMed     Abstract available


  510. CROWN A, Sevilimedu V, Morrow M
    Palpable Adenopathy Does Not Indicate High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2021 Apr 19. pii: 10.1245/s10434-021-09943.
    PubMed     Abstract available


  511. CROWN A, Morrow M
    ASO Author Reflections: Rethinking Palpable Adenopathy as a Marker of High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2021 Apr 19. pii: 10.1245/s10434-021-09984.
    PubMed    


  512. LIM DW, Retrouvey H, Kerrebijn I, Butler K, et al
    ASO Visual Abstract: Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer.
    Ann Surg Oncol. 2021 Apr 19. pii: 10.1245/s10434-021-10008.
    PubMed    


  513. GOMMERS JJJ, Duijm LEM, Voogd AC
    ASO Author Reflections: Impact of Preoperative MRI on Patients With Screen-Detected Invasive Breast Cancer Undergoing Breast-Conserving Surgery.
    Ann Surg Oncol. 2021 Apr 11. pii: 10.1245/s10434-021-09936.
    PubMed    


  514. CERVERA-BONILLA S, Guzman-Abisaab L, Rodriguez-Ossa P
    ASO Author Reflections: Evaluation of the 8th AJCC Prognostic Staging System for Breast Cancer in a Latin American Cohort.
    Ann Surg Oncol. 2021 Apr 9. pii: 10.1245/s10434-021-09959.
    PubMed    


  515. CERVERA-BONILLA S, Rodriguez-Ossa P, Vallejo-Ortega M, Osorio-Ruiz A, et al
    Evaluation of the AJCC Eighth-Edition Prognostic Staging System for Breast Cancer in a Latin American Cohort.
    Ann Surg Oncol. 2021 Apr 8. pii: 10.1245/s10434-021-09907.
    PubMed     Abstract available


  516. CAO L, Hue JJ, Freyvogel M, Li P, et al
    Despite Equivalent Outcomes, Men Receive Neoadjuvant Chemotherapy Less Often Than Women for Lymph Node-Positive Breast Cancer.
    Ann Surg Oncol. 2021 Apr 6. pii: 10.1245/s10434-021-09857.
    PubMed     Abstract available


  517. LIM DW, Retrouvey H, Kerrebijn I, Butler K, et al
    Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer.
    Ann Surg Oncol. 2021 Apr 5. pii: 10.1245/s10434-021-09928.
    PubMed     Abstract available


  518. WEISS A, Campbell J, Ballman KV, Sikov WM, et al
    Factors Associated with Nodal Pathologic Complete Response Among Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Results of CALGB 40601 (HER2+) and 40603 (Triple-Negative) (Alliance).
    Ann Surg Oncol. 2021 Apr 5. pii: 10.1245/s10434-021-09897.
    PubMed     Abstract available


  519. MCKEVITT E, Cheifetz R, DeVries K, Laws A, et al
    Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
    Ann Surg Oncol. 2021 Apr 5. pii: 10.1245/s10434-021-09839.
    PubMed     Abstract available


  520. GOMMERS JJJ, Duijm LEM, Bult P, Strobbe LJA, et al
    The Impact of Preoperative Breast MRI on Surgical Margin Status in Breast Cancer Patients Recalled at Biennial Screening Mammography: An Observational Cohort Study.
    Ann Surg Oncol. 2021 Apr 1. pii: 10.1245/s10434-021-09868.
    PubMed     Abstract available


  521. MARGENTHALER JA, Dietz JR, Chatterjee A
    The Landmark Series: Breast Conservation Trials (including oncoplastic breast surgery).
    Ann Surg Oncol. 2021;28:2120-2127.
    PubMed     Abstract available


  522. SROUR MK, Kim S, Amersi F, Giuliano AE, et al
    Comparison of Multiple Wire, Radioactive Seed, and Savi Scout((R)) Radar Localizations for Management of Surgical Breast Disease.
    Ann Surg Oncol. 2021;28:2212-2218.
    PubMed     Abstract available


  523. CROWN A, Handy N, Weed C, Laskin R, et al
    Oncoplastic Breast-Conserving Surgery: Can We Reduce Rates of Mastectomy and Chemotherapy Use in Patients with Traditional Indications for Mastectomy?
    Ann Surg Oncol. 2021;28:2199-2209.
    PubMed     Abstract available


  524. HELLER DR, Zhuo H, Zhang Y, Parikh N, et al
    Surgical Outcomes of Mastectomy with Immediate Autologous Reconstruction Followed by Radiation.
    Ann Surg Oncol. 2021;28:2169-2179.
    PubMed     Abstract available


  525. LEE KT, Bae J, Jeon BJ, Pyon JK, et al
    Adjuvant Chemotherapy in Two-Stage Tissue Expander/Implant Breast Reconstruction: Does it Affect Final Outcomes?
    Ann Surg Oncol. 2021;28:2191-2198.
    PubMed     Abstract available


  526. CROWN A, Rocha FG, Grumley J
    ASO Author Reflections: Oncoplastic Surgery Facilitates Breast Conservation and May Permit More Judicious Chemotherapy Use.
    Ann Surg Oncol. 2021;28:2210-2211.
    PubMed    


  527. TAMBURRINO D, Guarneri G, Capurso G, Falconi M, et al
    ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma.
    Ann Surg Oncol. 2021;28:2323-2324.
    PubMed    


  528. UZAN C, Mazouni C, Rossoni C, De Korvin B, et al
    Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions.
    Ann Surg Oncol. 2021;28:2138-2145.
    PubMed     Abstract available


  529. TAMBURRINO D, Guarneri G, Pagnanelli M, Crippa S, et al
    Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma: Legend or Scientific Evidence?
    Ann Surg Oncol. 2021;28:2312-2322.
    PubMed     Abstract available


  530. HELLER DR, Avraham T, Lannin DR, Killelea BK, et al
    ASO Author Reflections: An Evolving Approach to Autologous Reconstruction in the Setting of Postmastectomy Radiation.
    Ann Surg Oncol. 2021;28:2180-2181.
    PubMed    


    March 2021
  531. METCALFE KA, Eisen A, Poll A, Candib A, et al
    Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
    Ann Surg Oncol. 2021 Mar 24. pii: 10.1245/s10434-021-09855.
    PubMed     Abstract available


  532. MOHAN SC, Walcott-Sapp S, Lee MK, Srour MK, et al
    Alterations in Breast Cancer Biomarkers Following Neoadjuvant Therapy.
    Ann Surg Oncol. 2021 Mar 21. pii: 10.1245/s10434-021-09814.
    PubMed     Abstract available


  533. LV M, Li J, Guo H, Wang C, et al
    Correction to: Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
    Ann Surg Oncol. 2021 Mar 18. pii: 10.1245/s10434-021-09841.
    PubMed    


  534. ELDREDGE-HINDY H, Pan J, Rai SN, Reshko LB, et al
    A Phase II Trial of Once Weekly Hypofractionated Breast Irradiation for Early Stage Breast Cancer.
    Ann Surg Oncol. 2021 Mar 18. pii: 10.1245/s10434-021-09777.
    PubMed     Abstract available


  535. TANG A, Cohan CM, Beattie G, Cureton EL, et al
    Patients Older 65 Years With Early Breast Cancer Prefer Intraoperative Radiation as a Locoregional Treatment Choice.
    Ann Surg Oncol. 2021 Mar 9. pii: 10.1245/s10434-021-09618.
    PubMed     Abstract available


  536. TANG A, Shim V
    ASO Author Reflections: Balancing Patient Choice and Risks/Benefits of Radiation Treatment in Early Breast Cancer: How Does One Choose?
    Ann Surg Oncol. 2021 Mar 6. pii: 10.1245/s10434-021-09677.
    PubMed    


  537. RELATION T, Oppong BA
    ASO Author Reflections: Disparities in Outcome and Surgical Management Following Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2021 Mar 3. pii: 10.1245/s10434-021-09680.
    PubMed    


  538. CROWN A, Gonen M, Le T, Morrow M, et al
    Does Failure to Achieve Pathologic Complete Response with Neoadjuvant Chemotherapy Identify Node-Negative Patients Who Would Benefit from Postmastectomy Radiation or Regional Nodal Irradiation?
    Ann Surg Oncol. 2021;28:1328-1335.
    PubMed     Abstract available


  539. LAMB LR, Mercaldo S, Oseni TO, Bahl M, et al
    Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2021;28:1390-1397.
    PubMed     Abstract available


  540. COOK JA, Sasor SE, Loewenstein SN, DeBrock W, et al
    Immediate Lymphatic Reconstruction after Axillary Lymphadenectomy: A Single-Institution Early Experience.
    Ann Surg Oncol. 2021;28:1381-1387.
    PubMed     Abstract available


  541. LAW W, Look Hong N, Ravi A, Day L, et al
    Budget Impact Analysis of Preoperative Radioactive Seed Localization.
    Ann Surg Oncol. 2021;28:1370-1378.
    PubMed     Abstract available


  542. MOSELEY T, Desai B, Whitman GJ, Robinson EK, et al
    Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary?
    Ann Surg Oncol. 2021;28:1347-1355.
    PubMed     Abstract available


  543. TAMANUKI T, Namura M, Aoyagi T, Shimizu S, et al
    Effect of Intraoperative Imprint Cytology Followed by Frozen Section on Margin Assessment in Breast-Conserving Surgery.
    Ann Surg Oncol. 2021;28:1338-1346.
    PubMed     Abstract available


  544. LAW W, Look Hong N, Ravi A, Wright FC, et al
    ASO Author Reflections: Which Preoperative Breast Localization Method is More Economical: Radioactive Seed or Wire-Guided Localization?
    Ann Surg Oncol. 2021;28:1379-1380.
    PubMed    


  545. CROWN A, Morrow M
    ASO Author Reflections: Residual Disease in the Breast After Neoadjuvant Chemotherapy Does Not Mandate Routine Post-Mastectomy Radiation Therapy/Regional Nodal Irradiation.
    Ann Surg Oncol. 2021;28:1336-1337.
    PubMed    


  546. HE H, Whitman GJ, Moseley T
    ASO Author Reflections: Management of Benign Breast Intraductal Papillomas Without Atypia Diagnosed at Imaging-Guided Biopsies.
    Ann Surg Oncol. 2021;28:1356-1357.
    PubMed    


    February 2021
  547. MA JC, Zhong XR, Luo T, Xiang ZZ, et al
    Correction to: The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype.
    Ann Surg Oncol. 2021 Feb 26. pii: 10.1245/s10434-021-09771.
    PubMed    


  548. JONCZYK MM, Chatterjee A
    ASO Author Reflections: Predicting Complications in Breast Cancer Surgery Using the BCSRc.
    Ann Surg Oncol. 2021 Feb 26. pii: 10.1245/s10434-021-09763.
    PubMed    


  549. JONCZYK MM, Fisher CS, Babbitt R, Paulus JK, et al
    Surgical Predictive Model for Breast Cancer Patients Assessing Acute Postoperative Complications: The Breast Cancer Surgery Risk Calculator.
    Ann Surg Oncol. 2021 Feb 22. pii: 10.1245/s10434-021-09710.
    PubMed     Abstract available


  550. MA JC, Zhong XR, Luo T, Liu L, et al
    ASO Author Reflections: Postmastectomy Radiotherapy for Breast Cancer Patients After Neoadjuvant Chemotherapy, by Molecular Subtype.
    Ann Surg Oncol. 2021 Feb 18. pii: 10.1245/s10434-020-09555.
    PubMed    


  551. LV M, Li J, Guo H, Wang C, et al
    Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
    Ann Surg Oncol. 2021 Feb 17. pii: 10.1245/s10434-020-09548.
    PubMed     Abstract available


  552. OBENG-GYASI S, Asad S, Fisher JL, Rahurkar S, et al
    Socioeconomic and Surgical Disparities are Associated with Rapid Relapse in Patients with Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2021 Feb 14. pii: 10.1245/s10434-021-09688.
    PubMed     Abstract available


  553. MA JC, Zhong XR, Luo T, Xiang ZZ, et al
    The Effect of Postmastectomy Radiotherapy on Breast Cancer Patients After Neoadjuvant Chemotherapy by Molecular Subtype.
    Ann Surg Oncol. 2021 Feb 12. pii: 10.1245/s10434-020-09523.
    PubMed     Abstract available


  554. SORAN A, Dogan L, Ozbas S
    ASO Author Reflections: Locoregional Therapy in De Novo Bone-Only Metastatic Breast Cancer Provides Survival Advantage Regardless of Therapy Sequencing.
    Ann Surg Oncol. 2021 Feb 5. pii: 10.1245/s10434-021-09664.
    PubMed    


  555. YU Y, Hong H, Wang Y, Fu T, et al
    Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer.
    Ann Surg Oncol. 2021 Feb 3. pii: 10.1245/s10434-021-09650.
    PubMed     Abstract available


  556. SORAN A, Dogan L, Isik A, Ozbas S, et al
    The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study.
    Ann Surg Oncol. 2021 Feb 2. pii: 10.1245/s10434-021-09621.
    PubMed     Abstract available


  557. LV M, Luo S
    ASO Author Reflections: Impact of Ipsilateral Supraclavicular Lymph Node Dissection on Breast Cancer.
    Ann Surg Oncol. 2021 Feb 2. pii: 10.1245/s10434-020-09585.
    PubMed    


  558. PILTIN MA, Boughey JC
    ASO Author's Reflections: Are Genomic Assays Informing the Management of Ductal Carcinoma in situ as They Have for Invasive Breast Cancer?
    Ann Surg Oncol. 2021 Feb 1. pii: 10.1245/s10434-020-09573.
    PubMed    


  559. YANG L, Lu D, Lai Y, Shen M, et al
    Prognostic Score-Based Stratification Analysis Reveals Universal Benefits of Radiotherapy on Lowering the Risk of Ipsilateral Breast Event for Ductal Carcinoma In Situ Patients with Different Risk Levels.
    Ann Surg Oncol. 2021;28:975-984.
    PubMed     Abstract available


  560. MURPHY BL, Jakub JW, Asaad M, Day CN, et al
    Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients: When to Stop?
    Ann Surg Oncol. 2021;28:888-893.
    PubMed     Abstract available


  561. BALISKI C, Hughes L, Bakos B
    Lowering Re-excision Rates After Breast-Conserving Surgery: Unraveling the Intersection Between Surgeon Case Volumes and Techniques.
    Ann Surg Oncol. 2021;28:894-901.
    PubMed     Abstract available


    January 2021
  562. KENNARD K, Sizer LM, Frazier TG
    ASO Author Reflections: Changes in Breast Cancer Care and Patient Perception During the Initial Wave of COVID-19.
    Ann Surg Oncol. 2021 Jan 28. pii: 10.1245/s10434-020-09574.
    PubMed    


  563. KIM H, Lee SB, Nam SJ, Lee ES, et al
    Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer.
    Ann Surg Oncol. 2021 Jan 25. pii: 10.1245/s10434-021-09591.
    PubMed     Abstract available


  564. LEON-FERRE RA, Hieken TJ, Boughey JC
    The Landmark Series: Neoadjuvant Chemotherapy for Triple-Negative and HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2021 Jan 23. pii: 10.1245/s10434-020-09480.
    PubMed     Abstract available


  565. SMITH BD, Kuerer HM
    Same-Day Breast Cancer Surgery and TARGIT-IORT: Better than Selective Omission of Radiotherapy?
    Ann Surg Oncol. 2021 Jan 15. pii: 10.1245/s10434-021-09588.
    PubMed    


  566. SHAH C, Keisch M, Khan A, Arthur D, et al
    Ultra-Short Fraction Schedules as Part of De-intensification Strategies for Early-Stage Breast Cancer.
    Ann Surg Oncol. 2021 Jan 13. pii: 10.1245/s10434-020-09526.
    PubMed     Abstract available


  567. VALENTE SA, Tendulkar RD, Cherian S, Shah C, et al
    TARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.
    Ann Surg Oncol. 2021 Jan 12. pii: 10.1245/s10434-020-09432.
    PubMed     Abstract available


  568. COCCO D, Valente SA
    Sentinel Lymph Node Mapping and Biopsy in Breast Cancer Patients During the COVID-19 Pandemic.
    Ann Surg Oncol. 2021 Jan 11. pii: 10.1245/s10434-020-09554.
    PubMed    


  569. KANTOR O, Chang C, Yao K, Boughey J, et al
    Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers.
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09533.
    PubMed     Abstract available


  570. WU ZY, Kim HJ, Lee J, Chung IY, et al
    Oncologic Safety of Nipple-Sparing Mastectomy in Patients with Breast Cancer and Tumor-to-Nipple Distance
    Ann Surg Oncol. 2021 Jan 9. pii: 10.1245/s10434-020-09427.
    PubMed     Abstract available


  571. JAMES TA, Fan B
    ASO Author Reflections: Using Tumor Genomics to Predict Axillary Response to Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2021 Jan 8. pii: 10.1245/s10434-020-09455.
    PubMed    


  572. SIMONS JM, Scoggins ME, Kuerer HM, Krishnamurthy S, et al
    Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.
    Ann Surg Oncol. 2021 Jan 8. pii: 10.1245/s10434-020-09542.
    PubMed     Abstract available


  573. POSTLEWAIT LM, Lucci A
    ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy.
    Ann Surg Oncol. 2021 Jan 6. pii: 10.1245/s10434-020-09421.
    PubMed    


  574. PARTAIN N, Postlewait LM, Teshome M, Rosso K, et al
    The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2021 Jan 5. pii: 10.1245/s10434-020-09392.
    PubMed     Abstract available


  575. TADROS AB, Plitas G
    ASO Author Reflections: Clinical Importance of Histologic Subtype for Metaplastic Breast Cancer.
    Ann Surg Oncol. 2021 Jan 5. pii: 10.1245/s10434-020-09454.
    PubMed    


  576. ALLWEIS TM, Hermann N, Berenstein-Molho R, Guindy M, et al
    Personalized Screening for Breast Cancer: Rationale, Present Practices, and Future Directions.
    Ann Surg Oncol. 2021 Jan 4. pii: 10.1245/s10434-020-09426.
    PubMed     Abstract available


  577. PARDO JA, Fan B, Mele A, Serres S, et al
    The Role of Oncotype DX((R)) Recurrence Score in Predicting Axillary Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2021 Jan 3. pii: 10.1245/s10434-020-09382.
    PubMed     Abstract available


  578. ALLWEIS TM, Hermann N
    ASO Author Reflections: Will Breast Cancer Screening Become Personalized?
    Ann Surg Oncol. 2021 Jan 3. pii: 10.1245/s10434-020-09457.
    PubMed    


  579. KANTOR O, King TA
    ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
    Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09435.
    PubMed    


  580. TADROS AB, Sevilimedu V, Giri DD, Zabor EC, et al
    Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype.
    Ann Surg Oncol. 2021 Jan 2. pii: 10.1245/s10434-020-09430.
    PubMed     Abstract available


  581. PEPARINI N
    Beyond T, N, and M: Impact of Axillary Extranodal Tumor Deposits on the Treatment of Breast Cancer.
    Ann Surg Oncol. 2021 Jan 1. pii: 10.1245/s10434-020-09483.
    PubMed    


  582. DAVIES CF, Macefield R, Avery K, Blazeby JM, et al
    Patient-Reported Outcome Measures for Post-mastectomy Breast Reconstruction: A Systematic Review of Development and Measurement Properties.
    Ann Surg Oncol. 2021;28:386-404.
    PubMed     Abstract available


  583. CHU CK, Butler CE
    How Much Flap to Take? Invited Commentary on "Comparisons Between Normal Body Mass Index and Overweight Patients Who Underwent Unilateral Microsurgical Breast Reconstructions".
    Ann Surg Oncol. 2021;28:22-23.
    PubMed    


  584. CHENG MH, Koide S, Chen C, Lin YL, et al
    Comparisons Between Normal Body Mass Index and Overweight Patients Who Underwent Unilateral Microsurgical Breast Reconstructions.
    Ann Surg Oncol. 2021;28:353-362.
    PubMed     Abstract available


  585. ELMORE LC, Dietz JR, Myckatyn TM, Margenthaler JA, et al
    The Landmark Series: Mastectomy Trials (Skin-Sparing and Nipple-Sparing and Reconstruction Landmark Trials).
    Ann Surg Oncol. 2021;28:273-280.
    PubMed     Abstract available


  586. PETRUOLO O, Sevilimedu V, Montagna G, Le T, et al
    How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
    Ann Surg Oncol. 2021;28:287-294.
    PubMed     Abstract available


  587. MAMTANI A, Romanoff A, Baser R, Vincent A, et al
    Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?
    Ann Surg Oncol. 2021;28:295-302.
    PubMed     Abstract available


    December 2020
  588. VAN LOEVEZIJN AA, van Duijnhoven FH, Vrancken Peeters MTFD
    ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients.
    Ann Surg Oncol. 2020 Dec 10. pii: 10.1245/s10434-020-09324.
    PubMed    


  589. VAN LOEVEZIJN AA, van der Noordaa MEM, van Werkhoven ED, Loo CE, et al
    Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
    Ann Surg Oncol. 2020 Dec 2. pii: 10.1245/s10434-020-09273.
    PubMed     Abstract available


  590. SHAMS S, Lippold K, Blohmer JU, Rohle R, et al
    A Pilot Study Evaluating the Effects of Magtrace(R) for Sentinel Node Biopsy in Breast Cancer Patients Regarding Care Process Optimization, Reimbursement, Surgical Time, and Patient Comfort Compared With Standard Technetium(99).
    Ann Surg Oncol. 2020 Dec 1. pii: 10.1245/s10434-020-09280.
    PubMed     Abstract available


  591. CHANG SB
    ASO Author Reflections: We Can Do It: Using Non-Opioid Regimens After Breast Surgery.
    Ann Surg Oncol. 2020;27.
    PubMed    


  592. DINH KH, Diego EJ
    ASO Author Reflections: Improvement in Postoperative Pain, Nausea, and Vomiting After Implementation of an Enhanced Recovery Protocol for Breast Surgery.
    Ann Surg Oncol. 2020;27.
    PubMed    


  593. PHANTANA-ANGKOOL A, White RL Jr
    ASO Author Reflections: Is Sentinel Lymph Node Biopsy Necessary in Patients with Ductal Carcinoma In Situ with Microinvasion Diagnosed on Core Biopsy?
    Ann Surg Oncol. 2020;27.
    PubMed    


    November 2020
  594. PADILLA-RUIZ M, Zarcos-Pedrinaci I, Rivas-Ruiz F, Tellez T, et al
    Factors that Influence Treatment Delay for Patients with Breast Cancer.
    Ann Surg Oncol. 2020 Nov 27. pii: 10.1245/s10434-020-09409.
    PubMed     Abstract available


  595. PADILLA-RUIZ M, Redondo M
    ASO Author Reflections: Predictive Factors for Surgical Treatment Delay in Localised Breast Cancer.
    Ann Surg Oncol. 2020 Nov 24. pii: 10.1245/s10434-020-09411.
    PubMed    


  596. KANTOR O, Coopey SB
    Axillary Downstaging in ER(+)/HER(2-) Breast Cancer: OncotypeDX As a Tool to Guide Neoadjuvant Approach.
    Ann Surg Oncol. 2020 Nov 23. pii: 10.1245/s10434-020-09385.
    PubMed    


  597. TAMIRISA N, Lei X, Caudle AS, Giordano SH, et al
    Impact of SSO-ASTRO "No Ink on Tumor" Guidelines on Reexcision Rates among Older Breast Cancer Patients.
    Ann Surg Oncol. 2020 Nov 22. pii: 10.1245/s10434-020-09370.
    PubMed     Abstract available


  598. KAUFMAN CS, Cross MJ, Barone JL, Dekhne NS, et al
    A Three-Dimensional Bioabsorbable Tissue Marker for Volume Replacement and Radiation Planning: A Multicenter Study of Surgical and Patient-Reported Outcomes for 818 Patients with Breast Cancer.
    Ann Surg Oncol. 2020 Nov 21. pii: 10.1245/s10434-020-09271.
    PubMed     Abstract available


  599. JIWA N, Takats Z, Leff DR
    ASO Author Reflections: Diagnostic Accuracy of Nipple Aspirate Fluid Cytology in Asymptomatic Patients and Its Predictive Validity on Future Risk of Breast Cancer: A Meta-Analysis and Systematic Review of the Literature.
    Ann Surg Oncol. 2020 Nov 18. pii: 10.1245/s10434-020-09355.
    PubMed    


  600. SHAH C
    Intraoperative Radiation Therapy for Breast Cancer: Are We There Yet?
    Ann Surg Oncol. 2020 Nov 18. pii: 10.1245/s10434-020-09356.
    PubMed    


  601. KAUFMAN CS
    ASO Author Reflections: Is Survival Sufficient? There's More to Address for the Breast Cancer Surgeon.
    Ann Surg Oncol. 2020 Nov 17. pii: 10.1245/s10434-020-09350.
    PubMed    


  602. KEDRZYCKI MS, Elson DS, Leff DR
    ASO Author Reflections: Fluorescence-Guided Sentinel Node Biopsy for Breast Cancer.
    Ann Surg Oncol. 2020 Nov 13. pii: 10.1245/s10434-020-09344.
    PubMed    


  603. KARSTEN MM, Shams S, Kuhn F
    ASO Author Reflections: Non-radioactive Sentinel Node Localization with Superparamagnetic Iron Oxide in Clinically Node-Negative Breast Cancer Patients: A Possibility for Improvement of the Care Pathway.
    Ann Surg Oncol. 2020 Nov 10. pii: 10.1245/s10434-020-09325.
    PubMed    


  604. PERRY LM, Bateni SB, Sauder CAM
    ASO Author Reflections: Deescalating Therapy for Older Men with Early Estrogen Receptor Positive Breast Cancer.
    Ann Surg Oncol. 2020 Nov 9. pii: 10.1245/s10434-020-09357.
    PubMed    


  605. KEDRZYCKI MS, Leiloglou M, Ashrafian H, Jiwa N, et al
    Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery.
    Ann Surg Oncol. 2020 Nov 6. pii: 10.1245/s10434-020-09288.
    PubMed     Abstract available


  606. KUERER HM, Blair SL
    The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic.
    Ann Surg Oncol. 2020;27:4585-4587.
    PubMed    


    October 2020
  607. DA COSTA VIEIRA RA, de Oliveira-Junior I, Branquinho LI, Haikel RL, et al
    ASO Author Reflections: Modified External Oblique Myocutaneous Flap for Breast Cancer.
    Ann Surg Oncol. 2020 Oct 30. pii: 10.1245/s10434-020-09252.
    PubMed    


  608. STAHL K, Wong W, Dodge D, Brooks A, et al
    Benefits of Surgical Treatment of Stage IV Breast Cancer for Patients With Known Hormone Receptor and HER2 Status.
    Ann Surg Oncol. 2020 Oct 30. pii: 10.1245/s10434-020-09244.
    PubMed     Abstract available


  609. WONG SM, Boileau JF
    ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020 Oct 29. pii: 10.1245/s10434-020-09259.
    PubMed    


  610. STAHL K, Dodge D, Shen C
    ASO Author Reflections: Surgery Offers Survival Advantage in Treatment-Responsive Metastatic Breast Cancer.
    Ann Surg Oncol. 2020 Oct 28. pii: 10.1245/s10434-020-09286.
    PubMed    


  611. WONG SM, Basik M, Florianova L, Margolese R, et al
    Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer.
    Ann Surg Oncol. 2020 Oct 23. pii: 10.1245/s10434-020-09211.
    PubMed     Abstract available


  612. ZHANG J, Xiao L, Pu S, Liu Y, et al
    Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors.
    Ann Surg Oncol. 2020 Oct 23. pii: 10.1245/s10434-020-09214.
    PubMed     Abstract available


  613. BATENI SB, Perry LM, Zhao X, Arora M, et al
    The Role of Radiation Therapy in Addition to Lumpectomy and Hormone Therapy in Men 70 Years of Age and Older with Early Breast Cancer: A NCDB Analysis.
    Ann Surg Oncol. 2020 Oct 22. pii: 10.1245/s10434-020-09242.
    PubMed     Abstract available


  614. ANGARITA S, Ye L, Runger D, Hadaya J, et al
    Assessing the Burden of Nodal Disease for Breast Cancer Patients with Clinically Positive Nodes: Hope for More Limited Axillary Surgery.
    Ann Surg Oncol. 2020 Oct 21. pii: 10.1245/s10434-020-09228.
    PubMed     Abstract available


  615. OZKURT E, Wong S, Rhei E, Golshan M, et al
    Omission of Surgical Axillary Lymph Node Staging in Patients with Tubular Breast Cancer.
    Ann Surg Oncol. 2020 Oct 19. pii: 10.1245/s10434-020-09223.
    PubMed     Abstract available


  616. NIZIC-KOS T, Besic N
    ASO Author Reflections: Contralateral Prophylactic Mastectomy in Breast Cancer Patients with CHEK2 Gene Mutations.
    Ann Surg Oncol. 2020 Oct 18. pii: 10.1245/s10434-020-09196.
    PubMed    


  617. HELLER DR, Friedrich AU, Killelea BK
    Genetic Testing for Breast Cancer Patients: Is Everyone Who Needs a Test Getting a Test?
    Ann Surg Oncol. 2020 Oct 15. pii: 10.1245/s10434-020-09180.
    PubMed    


  618. OFFODILE AC 2ND, Asaad M, Boukovalas S, Bailey C, et al
    Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study.
    Ann Surg Oncol. 2020 Oct 13. pii: 10.1245/s10434-020-09216.
    PubMed     Abstract available


  619. BLOOM JA, Asban A, Tian T, Sekigami Y, et al
    A Cost-Utility Analysis Comparing Immediate Oncoplastic Surgery with Delayed Oncoplastic Surgery in Smoking Breast Cancer Patients.
    Ann Surg Oncol. 2020 Oct 13. pii: 10.1245/s10434-020-09220.
    PubMed     Abstract available


  620. ISHITOBI M, Hayashi N
    ASO Author Reflections: What will be Required to Safely Omit Breast Surgery for Early-Stage Breast Cancer?
    Ann Surg Oncol. 2020 Oct 12. pii: 10.1245/s10434-020-09195.
    PubMed    


  621. NIZIC-KOS T, Krajc M, Blatnik A, Stegel V, et al
    Bilateral Disease Common Among Slovenian CHEK2-Positive Breast Cancer Patients.
    Ann Surg Oncol. 2020 Oct 8. pii: 10.1245/s10434-020-09178.
    PubMed     Abstract available


  622. ISHITOBI M, Matsuda N, Tazo M, Nakayama S, et al
    Risk Factors for Ipsilateral Breast Tumor Recurrence in Triple-Negative or HER2-Positive Breast Cancer Patients Who Achieve a Pathologic Complete Response After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020 Oct 6. pii: 10.1245/s10434-020-09176.
    PubMed     Abstract available


  623. BERGSTROM CP, Pence C, Syed S
    ASO Author Reflections: Clinical Correlates of Moderate-Penetrance Genes in Breast Cancer.
    Ann Surg Oncol. 2020 Oct 1. pii: 10.1245/s10434-020-09187.
    PubMed    


  624. CYR AE, Sharma R
    Forewarned Is Forearmed: Can Better Patient Counseling Increase MRI Utilization in High-Risk Women?
    Ann Surg Oncol. 2020;27:3567-3569.
    PubMed    


  625. FISHER CS
    To Perform an Axillary Lymph Node Dissection or Not? That Is (Still) the Question.
    Ann Surg Oncol. 2020;27:3565-3566.
    PubMed    


  626. CROWN A, Grumley J
    ASO Author Reflections: Oncoplastic Surgery Does Not Compromise Surveillance Imaging.
    Ann Surg Oncol. 2020;27:3657-3658.
    PubMed    


  627. MONTAGNA G, Mamtani A, Knezevic A, Brogi E, et al
    Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020;27:4515-4522.
    PubMed     Abstract available


  628. MAGNONI F, Colleoni M, Mattar D, Corso G, et al
    Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?
    Ann Surg Oncol. 2020;27:4488-4499.
    PubMed     Abstract available


  629. TAKAHASHI H, Oshi M, Asaoka M, Yan L, et al
    Molecular Biological Features of Nottingham Histological Grade 3 Breast Cancers.
    Ann Surg Oncol. 2020;27:4475-4485.
    PubMed     Abstract available


  630. OSENI TO, Smith BL, Lehman CD, Vijapura CA, et al
    Do Eligibility Criteria for Ductal Carcinoma In Situ (DCIS) Active Surveillance Trials Identify Patients at Low Risk for Upgrade to Invasive Carcinoma?
    Ann Surg Oncol. 2020;27:4459-4465.
    PubMed     Abstract available


  631. OSENI TO, Bahl M
    ASO Author Reflections: Active Surveillance for Ductal Carcinoma In Situ (DCIS).
    Ann Surg Oncol. 2020;27:4466-4467.
    PubMed    


    September 2020
  632. BERGSTROM C, Pence C, Berg J, Partain N, et al
    Clinicopathological Features and Outcomes in Individuals with Breast Cancer and ATM, CHEK2, or PALB2 Mutations.
    Ann Surg Oncol. 2020 Sep 29. pii: 10.1245/s10434-020-09158.
    PubMed     Abstract available


  633. METCALFE KA, Eisen A, Poll A, Candib A, et al
    Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study.
    Ann Surg Oncol. 2020 Sep 28. pii: 10.1245/s10434-020-09160.
    PubMed     Abstract available


  634. CAO L, Xu C, Cai G, Qi WX, et al
    How Does the Interval Between Completion of Adjuvant Chemotherapy and Initiation of Radiotherapy Impact Clinical Outcomes in Operable Breast Cancer Patients?
    Ann Surg Oncol. 2020 Sep 24. pii: 10.1245/s10434-020-09026.
    PubMed     Abstract available


  635. GROVA MM, Strassle PD, Navajas EE, Gallagher KK, et al
    The Prognostic Value of Axillary Staging Following Neoadjuvant Chemotherapy in Inflammatory Breast Cancer.
    Ann Surg Oncol. 2020 Sep 24. pii: 10.1245/s10434-020-09152.
    PubMed     Abstract available


  636. BHUROSY T, Niu Z, Heckman CJ
    ASO Author Reflections: Is Breastfeeding Still Possible After Breast Cancer Treatment?
    Ann Surg Oncol. 2020 Sep 20. pii: 10.1245/s10434-020-09148.
    PubMed    


  637. TAMIRISA NP, Ren Y, Campbell BM, Thomas SM, et al
    Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases.
    Ann Surg Oncol. 2020 Sep 18. pii: 10.1245/s10434-020-09024.
    PubMed     Abstract available


  638. EGAN KG, De Souza M, Muenks E, Nazir N, et al
    Opioid Consumption Following Breast Surgery Decreases with a Brief Educational Intervention: A Randomized, Controlled Trial.
    Ann Surg Oncol. 2020;27:3156-3162.
    PubMed     Abstract available


  639. KEIM-MALPASS J, Anderson RT, Balkrishnan R, Desai RP, et al
    Evaluating the Long-Term Impact of a Cooperative Group Trial on Radiation Use and Adjuvant Endocrine Therapy Adherence Among Older Women.
    Ann Surg Oncol. 2020;27:3458-3465.
    PubMed     Abstract available


  640. PYFER BJ, Jonczyk M, Jean J, Graham RA, et al
    Analysis of Surgical Trends for Axillary Lymph Node Management in Patients with Ductal Carcinoma In Situ Using the NSQIP Database: Are We Following National Guidelines?
    Ann Surg Oncol. 2020;27:3448-3455.
    PubMed     Abstract available


  641. O'NEILL AC, Yang D, Roy M, Sebastiampillai S, et al
    Development and Evaluation of a Machine Learning Prediction Model for Flap Failure in Microvascular Breast Reconstruction.
    Ann Surg Oncol. 2020;27:3466-3475.
    PubMed     Abstract available


    August 2020
  642. FONG AJ, Lafaro K, Ituarte PHG, Fong Y, et al
    Association of Living in Urban Food Deserts with Mortality from Breast and Colorectal Cancer.
    Ann Surg Oncol. 2020 Aug 25. pii: 10.1245/s10434-020-09049.
    PubMed     Abstract available


  643. LIVINGSTON-ROSANOFF D, Trentham-Dietz A, Hampton JM, Newcomb PA, et al
    Evaluation of Long-Term Satisfaction with Breast Surgery in Patients Treated for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.
    Ann Surg Oncol. 2020;27:2628-2636.
    PubMed     Abstract available


  644. CASTELO M, Scheer AS
    ASO Author Reflections: Completion Axillary Dissection Can Be Avoided but Inconsistent Trial Design Complicates Choosing Between Alternative Strategies.
    Ann Surg Oncol. 2020;27:2677-2678.
    PubMed    


    July 2020
  645. KAIDAR-PERSON O, Boersma LJ, Poortmans P, Sklair-Levy M, et al
    Residual Glandular Breast Tissue After Mastectomy: A Systematic Review.
    Ann Surg Oncol. 2020;27:2288-2296.
    PubMed     Abstract available


  646. KAIDAR-PERSON O, Cardoso MJ
    ASO Author Reflections: Residual Breast Tissue After Skin- and Nipple-Sparing Mastectomies: A Matter of Concern or a Point for Improvement/Action?
    Ann Surg Oncol. 2020;27:2297-2298.
    PubMed    


  647. PALMER KELLY E, Hyer M, Paredes AZ, McGee J, et al
    Assessing Differences in Cancer Surgeon Approaches to Patient-Centered Decision-Making Using Vignette-Based Methodology.
    Ann Surg Oncol. 2020;27:2149-2156.
    PubMed     Abstract available


  648. HUDSON L, Gower N, Lenarcic S, Trufan SJ, et al
    Radiographic Surveillance of Patients with Non-BRCA1/2 Pathogenic Variants.
    Ann Surg Oncol. 2020;27:2248-2254.
    PubMed     Abstract available


  649. KLASSEN AF, Dominici L, Fuzesi S, Cano SJ, et al
    Development and Validation of the BREAST-Q Breast-Conserving Therapy Module.
    Ann Surg Oncol. 2020;27:2238-2247.
    PubMed     Abstract available


  650. WIBERG R, Andersson MN, Svensson J, Rosen A, et al
    Prophylactic Mastectomy: Postoperative Skin Flap Thickness Evaluated by MRT, Ultrasound and Clinical Examination.
    Ann Surg Oncol. 2020;27:2221-2228.
    PubMed     Abstract available


    June 2020

  651. The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors.
    Ann Surg Oncol. 2020;27:1793-1797.
    PubMed     Abstract available


  652. NERON M, Sajous C, Thezenas S, Piperno-Neumann S, et al
    Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study.
    Ann Surg Oncol. 2020;27:1818-1827.
    PubMed     Abstract available


  653. CORSO G, Maisonneuve P, Massari G, Invento A, et al
    Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma.
    Ann Surg Oncol. 2020;27:1864-1874.
    PubMed     Abstract available


  654. MINAMI CA, Zabor EC, Gilbert E, Newman A, et al
    Do Body Mass Index and Breast Density Impact Cancer Risk Among Women with Lobular Carcinoma In Situ?
    Ann Surg Oncol. 2020;27:1844-1851.
    PubMed     Abstract available


  655. NELSON JA, Sobti N, Patel A, Matros E, et al
    The Impact of Obesity on Patient-Reported Outcomes Following Autologous Breast Reconstruction.
    Ann Surg Oncol. 2020;27:1877-1888.
    PubMed     Abstract available


  656. MINAMI C, Pilewskie ML
    ASO Author Reflections: Conceptualizing Risk in Women with Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2020;27:1852-1853.
    PubMed    


  657. NERON M, Firmin N
    ASO Author Reflections: How Far Should We Go in Local Management for a Localized Malignant Phyllodes Tumor of the Breast?
    Ann Surg Oncol. 2020;27:1828-1829.
    PubMed    


  658. CORSO G
    ASO Author Reflections: Clinical Implication of Nomograms in the Breast Oncology Field.
    Ann Surg Oncol. 2020;27:1875-1876.
    PubMed    


    May 2020
  659. WU ZY, Kim HJ, Lee J, Chung IY, et al
    Recurrence Outcomes After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction in Patients with Pure Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2020;27:1627-1635.
    PubMed     Abstract available


  660. BARRIO AV, Downs-Canner S, Edelweiss M, Van Zee KJ, et al
    Microscopic Extracapsular Extension in Sentinel Lymph Nodes Does Not Mandate Axillary Dissection in Z0011-Eligible Patients.
    Ann Surg Oncol. 2020;27:1617-1624.
    PubMed     Abstract available


  661. NERON M, Sajous C, Thezenas S, Piperno-Neumann S, et al
    Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study.
    Ann Surg Oncol. 2020;27:1693-1699.
    PubMed     Abstract available


  662. MATEO AM, Mazor AM, Obeid E, Daly JM, et al
    Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes.
    Ann Surg Oncol. 2020;27:1679-1692.
    PubMed     Abstract available


  663. WARNER E, Yee S, Seminsky M, Glass K, et al
    Effect of a Knowledge-Translation Intervention on Breast Surgeons' Oncofertility Attitudes and Practices.
    Ann Surg Oncol. 2020;27:1645-1652.
    PubMed     Abstract available


  664. BOEHM KM, Chen J, Trichter S, Abdallah H, et al
    Characterization of Recurrences Following Second Breast-Conserving Surgery with Intraoperative Radiotherapy.
    Ann Surg Oncol. 2020;27:1638-1644.
    PubMed     Abstract available


  665. WU ZY, Ko B
    ASO Author Reflections: Risk of Locoregional Recurrence After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction for Pure Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2020;27:1636-1637.
    PubMed    


    April 2020
  666. SALMINEN SH, Blomqvist CP
    ASO Author Reflections: Registry-Based Analysis of Radiation-Associated Angiosarcoma of the Breast Provides Unbiased Insights into this Disease.
    Ann Surg Oncol. 2020;27:1011-1012.
    PubMed    


  667. DESNYDER SM
    Identifying Factors Predicting Long-Term Opioid Use After Mastectomy.
    Ann Surg Oncol. 2020;27:969-970.
    PubMed    


  668. CYR AE
    Underutilization of Enhanced Recovery After Surgery (ERAS) in Breast Surgery: An Opportunity to Reduce Opioid Usage.
    Ann Surg Oncol. 2020;27:966-968.
    PubMed    


  669. AGAFONOFF S, Kundu N, Schwarz G, Shah C, et al
    Immediate Implant Reconstruction in Patients Undergoing Radiation Therapy: Opportunities and Challenges.
    Ann Surg Oncol. 2020;27:963-965.
    PubMed    


  670. RAO R, Jackson RS, Rosen B, Brenin D, et al
    Pain Control in Breast Surgery: Survey of Current Practice and Recommendations for Optimizing Management-American Society of Breast Surgeons Opioid/Pain Control Workgroup.
    Ann Surg Oncol. 2020;27:985-990.
    PubMed     Abstract available


  671. WOESTE MR, Bhutiani N, Geller AE, Eldridge-Hindy H, et al
    Identifying Factors Predicting Prolonged Opioid Use After Mastectomy.
    Ann Surg Oncol. 2020;27:993-1001.
    PubMed     Abstract available


  672. SALMINEN SH, Wiklund T, Sampo MM, Tarkkanen M, et al
    Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population.
    Ann Surg Oncol. 2020;27:1002-1010.
    PubMed     Abstract available


    March 2020
  673. PARK KU, Kyrish K, Yi M, Bedrosian I, et al
    Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use.
    Ann Surg Oncol. 2020;27:730-735.
    PubMed     Abstract available


  674. CHRISTIAN N, Zabor EC, Cassidy M, Flynn J, et al
    Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2020;27:743-749.
    PubMed     Abstract available


  675. LEONARDI MC
    ASO Author Reflections: Repeat Quadrantectomy and Re-irradiation Is Safe and Effective Treatment for Local Recurrence After Partial Breast Irradiation.
    Ann Surg Oncol. 2020;27:763-764.
    PubMed    


  676. LEONARDI MC, Tomio L, Radice D, Takanen S, et al
    Local Failure After Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy with Electrons: An Insight into Management and Outcome from an Italian Multicentric Study.
    Ann Surg Oncol. 2020;27:752-762.
    PubMed     Abstract available


    February 2020
  677. PARK KU, Weiss A, Rosso K, Yi M, et al
    Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.
    Ann Surg Oncol. 2020;27:367-372.
    PubMed     Abstract available


  678. WARD WH, Bleicher RJ
    ASO Author Reflections: Delays in the Treatment of DCIS-What are the Costs?
    Ann Surg Oncol. 2020;27:397-398.
    PubMed    


  679. QIU PF, Wang YS
    ASO Author Reflections: Internal Mammary Sentinel Lymph Node Biopsy-Time for the Back of Internal Mammary Staging?
    Ann Surg Oncol. 2020;27:384-385.
    PubMed    


  680. COOPEY SB
    Much Ado About Nipples.
    Ann Surg Oncol. 2020;27:321-322.
    PubMed    


  681. ANKER AM, Prantl L, Klein SM
    ASO Author Reflections: The Silent Force Behind Microsurgery.
    Ann Surg Oncol. 2020;27:407-408.
    PubMed    


  682. PARK KU
    ASO Author Reflections: Key Challenges in Expanding the Utilization of Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2020;27:373-374.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: